| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.31e-09 | 18 | 273 | 7 | GO:0008569 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 5.81e-08 | 27 | 273 | 7 | GO:0008066 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 6.74e-08 | 17 | 273 | 6 | GO:0004970 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 7.66e-08 | 28 | 273 | 7 | GO:0051959 | |
| GeneOntologyMolecularFunction | sodium channel activity | 4.93e-07 | 52 | 273 | 8 | GO:0005272 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 5.99e-07 | 37 | 273 | 7 | GO:0045505 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 6.77e-07 | 24 | 273 | 6 | GO:0099507 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 5.00e-06 | 70 | 273 | 8 | GO:0003777 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | PIEZO1 ABCC8 SCN1A SCN5A SCN8A CACNA1H CACNA1G KCNT1 CACNA1A CACNA1E GRIA1 GRIA3 GRIK3 GRIK4 GRIK5 PEX5L KCNK7 | 5.47e-06 | 343 | 273 | 17 | GO:0005261 |
| GeneOntologyMolecularFunction | AMPA glutamate receptor activity | 1.00e-05 | 4 | 273 | 3 | GO:0004971 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DDX59 ABCA13 AK9 ATP8B1 ABCA7 ABCC8 DNAH5 DNAH6 DYNC1H1 ALPL DNAH3 RHOBTB3 FIGN ATP10D IQCA1 MACF1 DHX32 KIF18B DNAH11 | 1.15e-05 | 441 | 273 | 19 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX59 MYO7A ABCA13 AK9 ATP8B1 ABCA7 DNAH14 ABCC8 DNAH5 DNAH6 DYNC1H1 ALPL DNAH3 RHOBTB3 FIGN ATP10D DNAH1 IQCA1 MACF1 DHX32 KIF18B ATP6V0A2 DNAH11 | 1.34e-05 | 614 | 273 | 23 | GO:0140657 |
| GeneOntologyMolecularFunction | gated channel activity | PIEZO1 ABCC8 SCN1A CACNA1H CACNA1G KCNT1 CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 PEX5L KCNK7 | 1.58e-05 | 334 | 273 | 16 | GO:0022836 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | PIEZO1 ABCC8 SCN1A SCN5A SCN8A CACNA1H CACNA1G KCNT1 CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 OCA2 GRIK5 PEX5L KCNK7 | 2.00e-05 | 459 | 273 | 19 | GO:0005216 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.39e-05 | 26 | 273 | 5 | GO:0005248 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SCN1A SLC5A6 SCN5A SCN8A CACNA1H CACNA1G GRIK3 GRIK4 GRIK5 SLC1A6 SLC9A4 | 2.44e-05 | 171 | 273 | 11 | GO:0015081 |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 3.07e-05 | 14 | 273 | 4 | GO:0008331 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.57e-05 | 118 | 273 | 9 | GO:0003774 | |
| GeneOntologyMolecularFunction | channel activity | PIEZO1 ABCC8 SCN1A SCN5A SCN8A CACNA1H CACNA1G KCNT1 RHCG CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 OCA2 GRIK5 PEX5L KCNK7 | 3.93e-05 | 525 | 273 | 20 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | PIEZO1 ABCC8 SCN1A SCN5A SCN8A CACNA1H CACNA1G KCNT1 RHCG CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 OCA2 GRIK5 PEX5L KCNK7 | 4.04e-05 | 526 | 273 | 20 | GO:0022803 |
| GeneOntologyMolecularFunction | kainate selective glutamate receptor activity | 4.90e-05 | 6 | 273 | 3 | GO:0015277 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 7.43e-05 | 75 | 273 | 7 | GO:0098960 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | ABCC8 SCN1A SLC5A6 SCN5A SCN8A CACNA1H CACNA1G KCNT1 CACNA1A CACNA1E GRIA1 GRIA3 GRIK3 GRIK4 GRIK5 KCNK7 SLC1A6 SLC9A4 | 7.84e-05 | 465 | 273 | 18 | GO:0046873 |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.25e-04 | 57 | 273 | 6 | GO:1904315 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | ABCC8 SCN1A SLC5A6 SCN5A SCN8A CACNA1H CACNA1G KCNT1 RHCG CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 KCNK7 SLC1A6 SLC9A4 ATP6V0A2 | 1.56e-04 | 627 | 273 | 21 | GO:0022890 |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.67e-04 | 60 | 273 | 6 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 2.60e-04 | 65 | 273 | 6 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 2.60e-04 | 65 | 273 | 6 | GO:0022824 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | PIEZO1 ABCC8 SCN1A SLC5A6 SCN5A SCN8A CACNA1H CACNA1G KCNT1 CACNA1A CACNA1E GRIA1 GRIA3 GRIK3 GRIK4 GRIK5 PEX5L KCNK7 SLC1A6 SLC9A4 ATP6V0A2 | 3.38e-04 | 664 | 273 | 21 | GO:0008324 |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 4.48e-04 | 100 | 273 | 7 | GO:0030594 | |
| GeneOntologyMolecularFunction | dystroglycan binding | 5.08e-04 | 12 | 273 | 3 | GO:0002162 | |
| GeneOntologyMolecularFunction | mu-type opioid receptor binding | 5.54e-04 | 3 | 273 | 2 | GO:0031852 | |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 5.54e-04 | 3 | 273 | 2 | GO:0008332 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | PIEZO1 ABCC8 SCN1A SLC5A6 SCN5A SCN8A CACNA1H CACNA1G KCNT1 CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 OCA2 GRIK5 PEX5L KCNK7 SLC1A6 SLC9A4 ATP6V0A2 | 5.95e-04 | 793 | 273 | 23 | GO:0015075 |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 6.02e-04 | 105 | 273 | 7 | GO:0015171 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 6.51e-04 | 77 | 273 | 6 | GO:0005230 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 6.95e-04 | 140 | 273 | 8 | GO:0099094 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ABCC8 SCN1A SLC5A6 SCN5A SCN8A CACNA1H CACNA1G KCNT1 RHCG CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 OCA2 GRIK5 KCNK7 SLC1A6 SLC9A4 ATP6V0A2 | 7.75e-04 | 758 | 273 | 22 | GO:0015318 |
| GeneOntologyMolecularFunction | transporter activity | ABCA13 PIEZO1 ATP8B1 ABCA7 ABCC8 SCN1A SLC5A6 SCN5A OSBPL5 SCN8A CACNA1H CACNA1G KCNT1 RHCG CACNA1A CACNA1E SLC25A41 XKR8 GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 OCA2 GRIK5 PEX5L KCNK7 SLC1A6 ATP10D SLC22A9 SLC9A4 ATP6V0A2 | 8.00e-04 | 1289 | 273 | 32 | GO:0005215 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DDX59 ABCA13 AK9 ATP8B1 ABCA7 ABCC8 GNAS DNAH5 DNAH6 DYNC1H1 ARL14 ALPL DNAH3 RHOBTB3 FIGN ATP10D IQCA1 SAR1B MACF1 DHX32 KIF18B DNAH11 | 1.03e-03 | 775 | 273 | 22 | GO:0017111 |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 1.10e-03 | 4 | 273 | 2 | GO:0099583 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DDX59 ABCA13 AK9 ATP8B1 ABCA7 ABCC8 GNAS DNAH5 DNAH6 DYNC1H1 ARL14 ALPL DNAH3 RHOBTB3 FIGN ATP10D IQCA1 ASMTL SAR1B MACF1 DHX32 KIF18B DNAH11 | 1.26e-03 | 839 | 273 | 23 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DDX59 ABCA13 AK9 ATP8B1 ABCA7 ABCC8 GNAS DNAH5 DNAH6 DYNC1H1 ARL14 ALPL DNAH3 RHOBTB3 FIGN ATP10D IQCA1 ASMTL SAR1B MACF1 DHX32 KIF18B DNAH11 | 1.28e-03 | 840 | 273 | 23 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DDX59 ABCA13 AK9 ATP8B1 ABCA7 ABCC8 GNAS DNAH5 DNAH6 DYNC1H1 ARL14 ALPL DNAH3 RHOBTB3 FIGN ATP10D IQCA1 ASMTL SAR1B MACF1 DHX32 KIF18B DNAH11 | 1.28e-03 | 840 | 273 | 23 | GO:0016818 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.39e-03 | 193 | 273 | 9 | GO:0015276 | |
| GeneOntologyMolecularFunction | sulfuric ester hydrolase activity | 1.49e-03 | 17 | 273 | 3 | GO:0008484 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.61e-03 | 197 | 273 | 9 | GO:0022834 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 1.77e-03 | 18 | 273 | 3 | GO:0004016 | |
| GeneOntologyMolecularFunction | ligand-gated sodium channel activity | 1.77e-03 | 18 | 273 | 3 | GO:0015280 | |
| GeneOntologyMolecularFunction | testosterone 6-beta-hydroxylase activity | 1.81e-03 | 5 | 273 | 2 | GO:0050649 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 2.25e-03 | 207 | 273 | 9 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 2.33e-03 | 208 | 273 | 9 | GO:0005342 | |
| GeneOntologyMolecularFunction | microtubule plus-end binding | 3.21e-03 | 22 | 273 | 3 | GO:0051010 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCA13 PIEZO1 ABCA7 ABCC8 SCN1A SLC5A6 SCN5A SCN8A CACNA1H CACNA1G KCNT1 RHCG CACNA1A CACNA1E SLC25A41 GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 OCA2 GRIK5 PEX5L KCNK7 SLC1A6 SLC22A9 SLC9A4 ATP6V0A2 | 3.25e-03 | 1180 | 273 | 28 | GO:0022857 |
| GeneOntologyBiologicalProcess | regulation of presynaptic membrane potential | 1.40e-07 | 32 | 266 | 7 | GO:0099505 | |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 1.03e-06 | 27 | 266 | 6 | GO:0035235 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | RELN ABCC8 CACNA1A GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 NR3C1 GRM5 | 1.17e-06 | 132 | 266 | 11 | GO:0035249 |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 1.06e-05 | 59 | 266 | 7 | GO:0007215 | |
| GeneOntologyBiologicalProcess | ligand-gated ion channel signaling pathway | 1.16e-05 | 40 | 266 | 6 | GO:1990806 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | RELN PIEZO1 ABCC8 SCN1A SCN5A SCN8A CACNA1H CACNA1G KCNT1 CACNA1A GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 PEX5L GRM5 KCNK7 SLC1A6 IGSF9B | 1.30e-05 | 559 | 266 | 21 | GO:0042391 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 9.34e-05 | 36 | 266 | 5 | GO:0086010 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 1.03e-04 | 112 | 266 | 8 | GO:0019226 | |
| GeneOntologyCellularComponent | sodium channel complex | 8.79e-11 | 29 | 277 | 9 | GO:0034706 | |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 4.43e-07 | 6 | 277 | 4 | GO:0032983 | |
| GeneOntologyCellularComponent | dynein complex | 5.27e-07 | 54 | 277 | 8 | GO:0030286 | |
| GeneOntologyCellularComponent | microtubule associated complex | MAP2 DNAH14 HAUS8 DNAH5 DNAH6 DYNC1H1 DYNC1LI2 DNAH3 DNAH1 MAP1S KIF18B DNAH11 | 1.67e-06 | 161 | 277 | 12 | GO:0005875 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 2.14e-06 | 17 | 277 | 5 | GO:0001518 | |
| GeneOntologyCellularComponent | postsynaptic membrane | CSMD2 LIN7A SCN8A CACNA1H FLRT3 ADGRL2 KCNT1 CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 GRM5 SLC1A6 OPRK1 IGSF9B | 2.18e-06 | 405 | 277 | 19 | GO:0045211 |
| GeneOntologyCellularComponent | cation channel complex | ABCC8 SCN1A SCN5A SCN8A CACNA1H CACNA1G CACNA1A CACNA1E GRIA4 GRIK3 GRIK4 GRIK5 PEX5L CTTN | 3.30e-06 | 235 | 277 | 14 | GO:0034703 |
| GeneOntologyCellularComponent | postsynaptic density membrane | CSMD2 LIN7A SCN8A KCNT1 GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 GRM5 | 8.22e-06 | 157 | 277 | 11 | GO:0098839 |
| GeneOntologyCellularComponent | postsynaptic density | MAP2 CSMD2 DNAJC6 LIN7A DST SCN8A FLRT3 KCNT1 GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 NR3C1 GRM5 VPS35 MACF1 IGSF9B | 1.02e-05 | 451 | 277 | 19 | GO:0014069 |
| GeneOntologyCellularComponent | synaptic membrane | CSMD2 DNAJC6 LIN7A SCN1A SCN8A CACNA1H FLRT3 ADGRL2 KCNT1 CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 BCAN GRIK3 GRIK4 GRIK5 GRM5 SLC1A6 OPRK1 IGSF9B | 1.16e-05 | 583 | 277 | 22 | GO:0097060 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | ABCC8 SCN1A SCN5A SCN8A CACNA1H CACNA1G CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 PEX5L KCNK7 CTTN | 1.31e-05 | 378 | 277 | 17 | GO:0034702 |
| GeneOntologyCellularComponent | transporter complex | ATP8B1 ABCC8 SCN1A SCN5A SCN8A CACNA1H CACNA1G UQCRC2 CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 PEX5L KCNK7 ATP10D CTTN ATP6V0A2 | 1.55e-05 | 550 | 277 | 21 | GO:1990351 |
| GeneOntologyCellularComponent | presynaptic membrane | DNAJC6 SCN1A SCN8A CACNA1H CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 SLC1A6 OPRK1 | 2.14e-05 | 277 | 277 | 14 | GO:0042734 |
| GeneOntologyCellularComponent | asymmetric synapse | MAP2 CSMD2 DNAJC6 LIN7A DST SCN8A FLRT3 KCNT1 GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 NR3C1 GRM5 VPS35 MACF1 IGSF9B | 2.23e-05 | 477 | 277 | 19 | GO:0032279 |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 2.71e-05 | 45 | 277 | 6 | GO:0008328 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 3.49e-05 | 47 | 277 | 6 | GO:0031462 | |
| GeneOntologyCellularComponent | postsynapse | NCKAP1 MAP2 CSMD2 DNAJC6 CYP46A1 LIN7A DST SCN8A CACNA1H FLRT3 ADGRL2 KCNT1 DOCK1 CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 NR3C1 GRM5 SLC1A6 OPRK1 VPS35 MACF1 IGSF9B CTTN SENP7 | 3.74e-05 | 1018 | 277 | 30 | GO:0098794 |
| GeneOntologyCellularComponent | somatodendritic compartment | PCSK2 PDE1C RELN PDE9A MAP2 LMTK3 WLS CYP46A1 ADCY2 SCN1A VPS13A SCN8A CACNA1H CACNA1G GNAS DYNC1H1 CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 BCAN GRIK3 GRIK4 GRIK5 NR3C1 PEX5L GRM5 OPRK1 MAP1S VPS35 IGSF9B CTTN TMEM100 | 3.92e-05 | 1228 | 277 | 34 | GO:0036477 |
| GeneOntologyCellularComponent | perikaryon | PCSK2 RELN PDE9A CACNA1H CACNA1A CACNA1E GRIA3 GRIK3 GRIK4 GRIK5 OPRK1 TMEM100 | 4.54e-05 | 223 | 277 | 12 | GO:0043204 |
| GeneOntologyCellularComponent | postsynaptic specialization | MAP2 CSMD2 DNAJC6 LIN7A DST SCN8A FLRT3 KCNT1 GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 NR3C1 GRM5 VPS35 MACF1 IGSF9B | 4.58e-05 | 503 | 277 | 19 | GO:0099572 |
| GeneOntologyCellularComponent | sarcolemma | PDE9A DST ABCC8 SCN1A SCN5A CACNA1H GNAS FER1L5 VCAM1 COL6A3 OPRK1 | 4.86e-05 | 190 | 277 | 11 | GO:0042383 |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 5.00e-05 | 50 | 277 | 6 | GO:0098878 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | MAP2 CSMD2 DNAJC6 LIN7A DST SCN8A FLRT3 KCNT1 GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 NR3C1 GRM5 VPS35 MACF1 IGSF9B | 7.68e-05 | 523 | 277 | 19 | GO:0098984 |
| GeneOntologyCellularComponent | transmembrane transporter complex | ABCC8 SCN1A SCN5A SCN8A CACNA1H CACNA1G UQCRC2 CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 PEX5L KCNK7 CTTN ATP6V0A2 | 7.68e-05 | 523 | 277 | 19 | GO:1902495 |
| GeneOntologyCellularComponent | dendrite | PCSK2 RELN MAP2 LMTK3 WLS CYP46A1 ADCY2 SCN8A CACNA1H CACNA1G GNAS CACNA1A GRIA1 GRIA3 GRIA4 BCAN GRIK3 GRIK4 GRIK5 NR3C1 PEX5L GRM5 OPRK1 MAP1S IGSF9B CTTN | 8.07e-05 | 858 | 277 | 26 | GO:0030425 |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | CSMD2 LIN7A SCN8A KCNT1 GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 GRM5 | 8.08e-05 | 201 | 277 | 11 | GO:0099634 |
| GeneOntologyCellularComponent | dendritic tree | PCSK2 RELN MAP2 LMTK3 WLS CYP46A1 ADCY2 SCN8A CACNA1H CACNA1G GNAS CACNA1A GRIA1 GRIA3 GRIA4 BCAN GRIK3 GRIK4 GRIK5 NR3C1 PEX5L GRM5 OPRK1 MAP1S IGSF9B CTTN | 8.38e-05 | 860 | 277 | 26 | GO:0097447 |
| GeneOntologyCellularComponent | leading edge membrane | PDE9A NCKAP1 MAP2 PIEZO1 CLASP2 WLS ABCA7 GRIA1 CSPG4 MACF1 RASGRP2 | 1.19e-04 | 210 | 277 | 11 | GO:0031256 |
| GeneOntologyCellularComponent | neuronal cell body | PCSK2 PDE1C RELN PDE9A MAP2 SCN1A VPS13A SCN8A CACNA1H CACNA1G GNAS DYNC1H1 CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 OPRK1 MAP1S VPS35 IGSF9B TMEM100 | 1.34e-04 | 835 | 277 | 25 | GO:0043025 |
| GeneOntologyCellularComponent | inner dynein arm | 2.58e-04 | 10 | 277 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | cell body | PCSK2 PDE1C RELN PDE9A MAP2 SCN1A VPS13A SCN8A CACNA1H CACNA1G GNAS DYNC1H1 CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 OPRK1 MAP1S TMEM132E VPS35 IGSF9B TMEM100 | 2.83e-04 | 929 | 277 | 26 | GO:0044297 |
| GeneOntologyCellularComponent | motile cilium | PRAMEF5 DNAH14 FSIP2 VPS13A TAS2R45 DNAH5 TBC1D21 DNAH6 PRAMEF6 DNAH3 PRAMEF12 DNAH1 IQCA1 DNAH11 | 2.98e-04 | 355 | 277 | 14 | GO:0031514 |
| GeneOntologyCellularComponent | axonemal dynein complex | 3.06e-04 | 25 | 277 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | cytoplasmic region | MAP2 CLASP2 WLS DST DNAH5 DNAH6 DYNC1H1 DNAH3 CLASP1 GRIK3 TERF2 DNAH1 BBS7 DNAH11 | 3.43e-04 | 360 | 277 | 14 | GO:0099568 |
| GeneOntologyCellularComponent | ruffle | PDE9A NCKAP1 MAP2 CLASP2 ABCA7 GNAS CSPG4 MACF1 CTTN RASGRP2 | 4.43e-04 | 206 | 277 | 10 | GO:0001726 |
| GeneOntologyCellularComponent | microtubule plus-end | 4.81e-04 | 28 | 277 | 4 | GO:0035371 | |
| GeneOntologyCellularComponent | axon initial segment | 5.52e-04 | 29 | 277 | 4 | GO:0043194 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 5.93e-04 | 78 | 277 | 6 | GO:0048787 | |
| GeneOntologyCellularComponent | cell projection membrane | PDE9A NCKAP1 MAP2 PIEZO1 CLASP2 ATP8B1 WLS ABCA7 SLC5A6 GRIA1 BBS7 CSPG4 GUCY2D MACF1 RASGRP2 | 6.77e-04 | 431 | 277 | 15 | GO:0031253 |
| GeneOntologyCellularComponent | microtubule | MAP2 CLASP2 DNAH14 HAUS8 DST DNAH5 DNAH6 DYNC1H1 DYNC1LI2 DNAH3 CLASP1 FIGN DNAH1 MAP1S MACF1 KIF18B DNAH11 | 8.05e-04 | 533 | 277 | 17 | GO:0005874 |
| GeneOntologyCellularComponent | retromer, cargo-selective complex | 1.03e-03 | 4 | 277 | 2 | GO:0030906 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | MAP2 WLS DST DNAH5 DNAH6 DYNC1H1 DNAH3 GRIK3 TERF2 DNAH1 BBS7 DNAH11 | 1.13e-03 | 317 | 277 | 12 | GO:0032838 |
| GeneOntologyCellularComponent | microtubule end | 1.56e-03 | 38 | 277 | 4 | GO:1990752 | |
| GeneOntologyCellularComponent | cortical microtubule cytoskeleton | 1.70e-03 | 5 | 277 | 2 | GO:0030981 | |
| GeneOntologyCellularComponent | presynapse | DNAJC6 CYP46A1 LIN7A ABCC8 SCN1A SCN8A CACNA1H FLRT3 FER1L5 CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 SLC1A6 OPRK1 MYOF VPS35 ATM SENP7 | 1.72e-03 | 886 | 277 | 23 | GO:0098793 |
| GeneOntologyCellularComponent | node of Ranvier | 2.22e-03 | 20 | 277 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | 9+0 motile cilium | 2.53e-03 | 6 | 277 | 2 | GO:0097728 | |
| GeneOntologyCellularComponent | potassium channel complex | 2.63e-03 | 104 | 277 | 6 | GO:0034705 | |
| GeneOntologyCellularComponent | lysosome | PDE1C MAN2B1 MYO7A ARSK ABCA13 VPS13A DYNC1H1 BCAN SPAG9 OCA2 IDS TASL EPG5 USP5 ARSD CSPG4 SAR1B VPS35 PADI2 STOM ATP6V0A2 | 2.78e-03 | 811 | 277 | 21 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | PDE1C MAN2B1 MYO7A ARSK ABCA13 VPS13A DYNC1H1 BCAN SPAG9 OCA2 IDS TASL EPG5 USP5 ARSD CSPG4 SAR1B VPS35 PADI2 STOM ATP6V0A2 | 2.78e-03 | 811 | 277 | 21 | GO:0000323 |
| GeneOntologyCellularComponent | lamellipodium membrane | 2.94e-03 | 22 | 277 | 3 | GO:0031258 | |
| GeneOntologyCellularComponent | glutamatergic synapse | MAP2 CLASP2 CSMD2 SCN8A CACNA1H FLRT3 ADGRL2 DOCK1 CACNA1A GRIA1 GRIA3 GRIA4 BCAN GRIK3 GRIK4 GRIK5 NR3C1 GRM5 SLC1A6 VPS35 CTTN | 3.03e-03 | 817 | 277 | 21 | GO:0098978 |
| GeneOntologyCellularComponent | ruffle membrane | 3.18e-03 | 108 | 277 | 6 | GO:0032587 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 3.18e-03 | 46 | 277 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 3.48e-03 | 110 | 277 | 6 | GO:0120111 | |
| GeneOntologyCellularComponent | basal cortex | 3.52e-03 | 7 | 277 | 2 | GO:0045180 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | MON2 ACAP1 ABCA13 WLS MYCBPAP ABCA7 LIN7A SPG21 ABCC8 ADGRE3 VPS13A TMX3 FER1L5 TAPBP GRIA1 GRIA3 GRIA4 OCA2 TASL OPRK1 MYOF SLC9A4 SEC24C SAR1B VPS35 ATM VPS29 STOM ATP6V0A2 | 4.59e-03 | 1307 | 277 | 29 | GO:0030659 |
| GeneOntologyCellularComponent | 9+2 motile cilium | 4.62e-03 | 238 | 277 | 9 | GO:0097729 | |
| GeneOntologyCellularComponent | membrane protein complex | MYCBPAP TTC19 LIN7A ABCC8 SCN1A SCN5A SCN8A CACNA1H CACNA1G UQCRC2 GNAS TAPBP VCAM1 CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 PEX5L KCNK7 SLC1A6 NPLOC4 LRRN3 SEC24C SAR1B VPS35 CTTN VPS29 ATP6V0A2 | 5.16e-03 | 1498 | 277 | 32 | GO:0098796 |
| GeneOntologyCellularComponent | vacuole | PDE1C MAN2B1 MYO7A ARSK ABCA13 VPS13A SRPX DYNC1H1 BCAN SPAG9 OCA2 IDS TASL EPG5 USP5 ARSD CSPG4 SAR1B VPS35 PADI2 STOM ATP6V0A2 | 5.21e-03 | 913 | 277 | 22 | GO:0005773 |
| GeneOntologyCellularComponent | mitotic spindle | 5.49e-03 | 201 | 277 | 8 | GO:0072686 | |
| GeneOntologyCellularComponent | vesicle membrane | MON2 ACAP1 ABCA13 WLS MYCBPAP ABCA7 LIN7A SPG21 ABCC8 ADGRE3 VPS13A TMX3 FER1L5 TAPBP GRIA1 GRIA3 GRIA4 OCA2 TASL OPRK1 MYOF SLC9A4 SEC24C SAR1B VPS35 ATM VPS29 STOM ATP6V0A2 | 5.54e-03 | 1325 | 277 | 29 | GO:0012506 |
| HumanPheno | Impairment in personality functioning | RELN DDX59 MAN2B1 GAMT MYO7A PTPN22 ATP8B1 DNAJC6 ABCA7 PXK TTC19 SPG21 FOCAD FBXO28 SCN1A VPS13A SCN8A CACNA1H CACNA1G TAF1 GNAS HEPHL1 CAMTA1 NIPBL KCNT1 PHIP MED12 RIC1 TBL1X CACNA1A FAT4 GRIA1 GRIA3 OCA2 TDO2 ZSWIM6 NR3C1 BBS10 LHCGR SEC24C BBS7 GUCY2D VPS35 ATM | 7.87e-08 | 1141 | 93 | 44 | HP:0031466 |
| HumanPheno | Abnormal social development | RELN DDX59 GAMT WLS DNAJC6 ABCA7 TTC19 FOCAD ABCC8 FBXO28 SCN1A VPS13A SCN8A CACNA1H CACNA1G TAF1 GNAS HEPHL1 CAMTA1 NIPBL KCNT1 PHIP MED12 RIC1 TBL1X CACNA1A FAT4 GRIA1 GRIA3 OCA2 TDO2 ZSWIM6 LHCGR SEC24C GUCY2D VPS35 ATM | 4.24e-07 | 908 | 93 | 37 | HP:0025732 |
| HumanPheno | Abnormal motivation | RELN DDX59 MAN2B1 GAMT MYO7A PTPN22 ATP8B1 DNAJC6 ABCA7 PXK TTC19 SPG21 FOCAD ABCC8 FBXO28 SCN1A VPS13A SCN8A CACNA1H CACNA1G TAF1 GNAS HEPHL1 CAMTA1 NIPBL KCNT1 PHIP MED12 RIC1 TBL1X CACNA1A FAT4 GRIA1 GRIA3 OCA2 TDO2 ZSWIM6 NR3C1 BBS10 LHCGR SEC24C BBS7 GUCY2D VPS35 ATM | 5.82e-07 | 1263 | 93 | 45 | HP:5200275 |
| HumanPheno | Abnormal volitional state | RELN DDX59 MAN2B1 GAMT MYO7A PTPN22 ATP8B1 DNAJC6 ABCA7 PXK TTC19 SPG21 FOCAD ABCC8 FBXO28 SCN1A VPS13A SCN8A CACNA1H CACNA1G TAF1 GNAS HEPHL1 CAMTA1 NIPBL KCNT1 PHIP MED12 RIC1 TBL1X CACNA1A FAT4 GRIA1 GRIA3 OCA2 TDO2 ZSWIM6 NR3C1 BBS10 LHCGR SEC24C BBS7 GUCY2D VPS35 ATM | 5.82e-07 | 1263 | 93 | 45 | HP:0025780 |
| HumanPheno | Disinhibition | RELN DDX59 GAMT DNAJC6 ABCA7 TTC19 FOCAD FBXO28 SCN1A VPS13A SCN8A CACNA1H TAF1 GNAS HEPHL1 CAMTA1 NIPBL KCNT1 PHIP MED12 RIC1 TBL1X CACNA1A FAT4 GRIA1 GRIA3 OCA2 TDO2 ZSWIM6 LHCGR SEC24C GUCY2D VPS35 ATM | 7.38e-07 | 807 | 93 | 34 | HP:0000734 |
| HumanPheno | Inappropriate behavior | RELN DDX59 GAMT DNAJC6 ABCA7 TTC19 FOCAD FBXO28 SCN1A VPS13A SCN8A CACNA1H TAF1 GNAS HEPHL1 CAMTA1 NIPBL KCNT1 PHIP MED12 RIC1 TBL1X CACNA1A FAT4 GRIA1 GRIA3 OCA2 TDO2 ZSWIM6 LHCGR SEC24C GUCY2D VPS35 ATM | 7.38e-07 | 807 | 93 | 34 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | RELN DDX59 GAMT DNAJC6 ABCA7 TTC19 FOCAD FBXO28 SCN1A VPS13A SCN8A CACNA1H TAF1 GNAS HEPHL1 CAMTA1 NIPBL KCNT1 PHIP MED12 RIC1 TBL1X CACNA1A FAT4 GRIA1 GRIA3 OCA2 TDO2 ZSWIM6 LHCGR SEC24C GUCY2D VPS35 ATM | 7.38e-07 | 807 | 93 | 34 | HP:5200123 |
| HumanPheno | Social disinhibition | RELN DDX59 GAMT DNAJC6 ABCA7 TTC19 FOCAD FBXO28 SCN1A VPS13A SCN8A CACNA1H TAF1 GNAS HEPHL1 CAMTA1 NIPBL KCNT1 PHIP MED12 RIC1 TBL1X CACNA1A FAT4 GRIA1 GRIA3 OCA2 TDO2 ZSWIM6 LHCGR SEC24C GUCY2D VPS35 ATM | 7.38e-07 | 807 | 93 | 34 | HP:5200029 |
| HumanPheno | Short attention span | MAN2B1 DNAJC6 FOCAD FBXO28 SCN1A VPS13A SCN8A CACNA1H TAF1 CAMTA1 NIPBL KCNT1 PHIP MED12 RIC1 TBL1X CACNA1A GRIA1 GRIA4 OCA2 IDS BBS10 LHCGR SEC24C BBS7 ATM | 9.15e-07 | 517 | 93 | 26 | HP:0000736 |
| HumanPheno | Recurrent maladaptive behavior | RELN DDX59 MAN2B1 GAMT MYO7A PTPN22 DNAJC6 ABCA7 PXK TTC19 FOCAD ABCC8 FBXO28 SCN1A VPS13A SCN8A CACNA1H TAF1 GNAS HEPHL1 CAMTA1 NIPBL KCNT1 PHIP MED12 RIC1 ALPL TBL1X CACNA1A FAT4 BICRA GRIA1 GRIA3 OCA2 TDO2 ZSWIM6 NR3C1 BBS10 LHCGR SEC24C BBS7 GUCY2D VPS35 MACF1 ATM | 1.18e-06 | 1293 | 93 | 45 | HP:5200241 |
| HumanPheno | Reduced attention regulation | MAN2B1 DNAJC6 FOCAD FBXO28 SCN1A VPS13A SCN8A CACNA1H TAF1 CAMTA1 NIPBL KCNT1 PHIP MED12 RIC1 TBL1X CACNA1A GRIA1 GRIA4 OCA2 IDS BBS10 LHCGR SEC24C BBS7 ATM | 1.28e-06 | 526 | 93 | 26 | HP:5200044 |
| HumanPheno | Abnormally increased volition | RELN DDX59 GAMT DNAJC6 ABCA7 TTC19 FOCAD ABCC8 FBXO28 SCN1A VPS13A SCN8A CACNA1H TAF1 GNAS HEPHL1 CAMTA1 NIPBL KCNT1 PHIP MED12 RIC1 TBL1X CACNA1A FAT4 GRIA1 GRIA3 OCA2 TDO2 ZSWIM6 LHCGR SEC24C GUCY2D VPS35 ATM | 1.40e-06 | 869 | 93 | 35 | HP:5200263 |
| HumanPheno | Reduced impulse control | RELN DDX59 GAMT PTPN22 DNAJC6 ABCA7 PXK TTC19 FOCAD ABCC8 FBXO28 SCN1A VPS13A SCN8A CACNA1H TAF1 GNAS HEPHL1 CAMTA1 NIPBL KCNT1 PHIP MED12 RIC1 ALPL TBL1X CACNA1A FAT4 GRIA1 GRIA3 OCA2 TDO2 ZSWIM6 LHCGR SEC24C GUCY2D VPS35 ATM | 3.76e-06 | 1032 | 93 | 38 | HP:5200045 |
| HumanPheno | Depression | RELN MAN2B1 MYO7A PTPN22 ATP8B1 DNAJC6 ABCA7 PXK TTC19 VPS13A CACNA1H CACNA1G GNAS KCNT1 GRIA1 TDO2 NR3C1 BBS10 SEC24C BBS7 VPS35 ATM | 1.17e-05 | 448 | 93 | 22 | HP:0000716 |
| HumanPheno | Cerebral cortical atrophy | MAN2B1 MYO7A ABCA7 TTC19 VPS13A CAMTA1 TSEN15 NIPBL KCNT1 CACNA1A CACNA1E BICRA GRIA3 GRIA4 OCA2 ZSWIM6 EPG5 VPS35 | 3.99e-05 | 346 | 93 | 18 | HP:0002120 |
| HumanPheno | Focal automatism seizure | 4.61e-05 | 12 | 93 | 4 | HP:0032898 | |
| HumanPheno | Abnormal psychotic pattern | MYO7A PTPN22 TTC19 SCN1A VPS13A GNAS FAR1 KCNT1 MED12 CACNA1A OCA2 NR3C1 SEC24C VPS35 | 5.76e-05 | 229 | 93 | 14 | HP:5200430 |
| HumanPheno | Epileptic aura | 7.25e-05 | 25 | 93 | 5 | HP:0033348 | |
| HumanPheno | Abnormal diminished volition | RELN MAN2B1 MYO7A PTPN22 ATP8B1 DNAJC6 ABCA7 PXK TTC19 SPG21 ABCC8 SCN1A VPS13A CACNA1H CACNA1G GNAS KCNT1 CACNA1A GRIA1 TDO2 NR3C1 BBS10 SEC24C BBS7 VPS35 ATM | 8.86e-05 | 664 | 93 | 26 | HP:0000745 |
| HumanPheno | Aggressive behavior | RELN GAMT DNAJC6 TTC19 FBXO28 SCN1A VPS13A SCN8A HEPHL1 CAMTA1 NIPBL KCNT1 PHIP MED12 CACNA1A FAT4 GRIA1 GRIA3 OCA2 TDO2 GUCY2D VPS35 | 1.04e-04 | 516 | 93 | 22 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | RELN GAMT DNAJC6 TTC19 FBXO28 SCN1A VPS13A SCN8A HEPHL1 CAMTA1 NIPBL KCNT1 PHIP MED12 CACNA1A FAT4 GRIA1 GRIA3 OCA2 TDO2 GUCY2D VPS35 | 1.04e-04 | 516 | 93 | 22 | HP:0006919 |
| HumanPheno | Hallucinations | RELN MAN2B1 MYO7A PTPN22 DNAJC6 ABCA7 TTC19 MED12 CACNA1A VPS35 ATM | 1.37e-04 | 160 | 93 | 11 | HP:0000738 |
| HumanPheno | Psychosis | PTPN22 TTC19 SCN1A VPS13A GNAS FAR1 KCNT1 MED12 CACNA1A OCA2 NR3C1 | 1.45e-04 | 161 | 93 | 11 | HP:0000709 |
| HumanPheno | Abnormal experience of reality | RELN MAN2B1 MYO7A PTPN22 DNAJC6 ABCA7 TTC19 SCN1A VPS13A CACNA1H TAF1 GNAS FAR1 NIPBL KCNT1 PHIP MED12 CACNA1A OCA2 NR3C1 BBS10 SEC24C BBS7 VPS35 ATM | 1.53e-04 | 646 | 93 | 25 | HP:5200423 |
| HumanPheno | Complex febrile seizure | 1.60e-04 | 16 | 93 | 4 | HP:0011172 | |
| HumanPheno | Delayed speech and language development | RALGAPA1 MAN2B1 GAMT LAMA1 WLS FOCAD TAF8 FBXO28 SCN1A SCN8A CACNA1G TAF1 GNAS CAMTA1 FAR1 DNAH5 TSEN15 NIPBL KCNT1 MED12 DYNC1H1 RIC1 CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 OCA2 ZSWIM6 BBS10 DNAH1 BBS7 MACF1 ATM ATP6V0A2 DNAH11 | 1.81e-04 | 1123 | 93 | 36 | HP:0000750 |
| HumanPheno | Athetosis | GAMT SPG21 ABCC8 FBXO28 SCN1A VPS13A SCN8A GNAS TSEN15 CACNA1A ATM | 1.90e-04 | 166 | 93 | 11 | HP:0002305 |
| HumanPheno | Abnormal hippocampus morphology | 2.08e-04 | 48 | 93 | 6 | HP:0025100 | |
| HumanPheno | Language impairment | RALGAPA1 MAN2B1 GAMT LAMA1 WLS ABCA7 FOCAD TAF8 FBXO28 SCN1A SCN8A CACNA1G TAF1 GNAS CAMTA1 FAR1 DNAH5 TSEN15 NIPBL KCNT1 MED12 DYNC1H1 RIC1 CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 OCA2 ZSWIM6 BBS10 DNAH1 BBS7 MACF1 ATM ATP6V0A2 DNAH11 | 2.15e-04 | 1178 | 93 | 37 | HP:0002463 |
| HumanPheno | Abnormal morphology of the limbic system | 2.34e-04 | 49 | 93 | 6 | HP:0007343 | |
| HumanPheno | Otitis media | MAN2B1 PTPN22 FOCAD TAF1 HEPHL1 DNAH5 NIPBL PHIP MED12 RIC1 IDS BBS10 DNAH1 SEC24C CD19 BBS7 DNAH11 | 2.47e-04 | 363 | 93 | 17 | HP:0000388 |
| HumanPheno | Personality disorder | 2.62e-04 | 18 | 93 | 4 | HP:0012075 | |
| HumanPheno | Diplopia | 2.80e-04 | 94 | 93 | 8 | HP:0000651 | |
| HumanPheno | Abnormality of binocular vision | 2.80e-04 | 94 | 93 | 8 | HP:0011514 | |
| HumanPheno | Involuntary movements | GAMT LAMA1 PTPN22 ATP8B1 DNAJC6 LYST ABCA7 PXK TTC19 SPG21 ABCC8 FBXO28 SCN1A VPS13A SCN8A CACNA1H CACNA1G FLRT3 TAF1 GNAS CAMTA1 FAR1 TSEN15 KCNT1 PHIP CACNA1A CACNA1E COL6A3 BICRA GRIA1 GRIA3 GRIA4 OCA2 ZSWIM6 GUCY2D VPS35 MACF1 ATM | 3.28e-04 | 1248 | 93 | 38 | HP:0004305 |
| MousePheno | increased circulating amylase level | PCSK2 PRAMEF5 MAN2A1 AGL PZP RNF145 PRAMEF6 GRIA1 PRAMEF12 EPG5 | 1.26e-05 | 119 | 211 | 10 | MP:0008806 |
| MousePheno | abnormal behavioral response to xenobiotic | LMTK3 LYST SCN1A SCN8A CACNA1G GNAS NIPBL KCNT1 CACNA1A GRIA1 GRIA3 GRIA4 GRIK5 ZSWIM6 GRM5 OPRK1 | 1.87e-05 | 309 | 211 | 16 | MP:0009745 |
| MousePheno | abnormal spike wave discharge | 2.51e-05 | 24 | 211 | 5 | MP:0008840 | |
| MousePheno | impaired ability to fire action potentials | 3.24e-05 | 13 | 211 | 4 | MP:0002578 | |
| Domain | MT | 4.37e-10 | 14 | 275 | 7 | PF12777 | |
| Domain | AAA_8 | 4.37e-10 | 14 | 275 | 7 | PF12780 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.37e-10 | 14 | 275 | 7 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.37e-10 | 14 | 275 | 7 | IPR024743 | |
| Domain | DHC_fam | 8.09e-10 | 15 | 275 | 7 | IPR026983 | |
| Domain | Dynein_heavy | 8.09e-10 | 15 | 275 | 7 | PF03028 | |
| Domain | Dynein_heavy_dom | 8.09e-10 | 15 | 275 | 7 | IPR004273 | |
| Domain | ANF_lig-bd_rcpt | 2.48e-09 | 37 | 275 | 9 | IPR001828 | |
| Domain | ANF_receptor | 2.48e-09 | 37 | 275 | 9 | PF01094 | |
| Domain | Peripla_BP_I | 4.11e-09 | 39 | 275 | 9 | IPR028082 | |
| Domain | ATPase_dyneun-rel_AAA | 2.62e-08 | 14 | 275 | 6 | IPR011704 | |
| Domain | AAA_5 | 2.62e-08 | 14 | 275 | 6 | PF07728 | |
| Domain | Dynein_heavy_dom-2 | 2.62e-08 | 14 | 275 | 6 | IPR013602 | |
| Domain | DHC_N2 | 2.62e-08 | 14 | 275 | 6 | PF08393 | |
| Domain | Glu/Gly-bd | 1.54e-07 | 18 | 275 | 6 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 1.54e-07 | 18 | 275 | 6 | SM00918 | |
| Domain | Iontro_rcpt | 1.54e-07 | 18 | 275 | 6 | IPR001320 | |
| Domain | PBPe | 1.54e-07 | 18 | 275 | 6 | SM00079 | |
| Domain | Lig_chan-Glu_bd | 1.54e-07 | 18 | 275 | 6 | PF10613 | |
| Domain | Iono_rcpt_met | 1.54e-07 | 18 | 275 | 6 | IPR001508 | |
| Domain | Lig_chan | 1.54e-07 | 18 | 275 | 6 | PF00060 | |
| Domain | ARM-type_fold | MON2 RALGAPA1 SMG1 MROH5 CLASP2 USP9Y LYST FOCAD URB1 NIPBL DOCK1 PPP4R1 CLASP1 WDFY4 IPO9 PPP2R5E VPS35 NUP188 ATM | 7.22e-07 | 339 | 275 | 19 | IPR016024 |
| Domain | VDCCAlpha1 | 9.01e-06 | 10 | 275 | 4 | IPR002077 | |
| Domain | - | 1.96e-05 | 57 | 275 | 7 | 1.20.120.350 | |
| Domain | Channel_four-helix_dom | 1.96e-05 | 57 | 275 | 7 | IPR027359 | |
| Domain | TMEM132D_N | 3.09e-05 | 5 | 275 | 3 | PF15705 | |
| Domain | TMEM132D_C | 3.09e-05 | 5 | 275 | 3 | PF15706 | |
| Domain | TMEM132 | 3.09e-05 | 5 | 275 | 3 | IPR026307 | |
| Domain | TMEM132_M | 3.09e-05 | 5 | 275 | 3 | IPR031437 | |
| Domain | TMEM132_C | 3.09e-05 | 5 | 275 | 3 | IPR031436 | |
| Domain | TMEM132_N | 3.09e-05 | 5 | 275 | 3 | IPR031435 | |
| Domain | TMEM132 | 3.09e-05 | 5 | 275 | 3 | PF16070 | |
| Domain | AAA+_ATPase | ABCA13 AK9 ABCA7 ABCC8 DNAH5 DNAH6 DYNC1H1 DNAH3 FIGN DNAH11 | 5.52e-05 | 144 | 275 | 10 | IPR003593 |
| Domain | AAA | ABCA13 AK9 ABCA7 ABCC8 DNAH5 DNAH6 DYNC1H1 DNAH3 FIGN DNAH11 | 5.52e-05 | 144 | 275 | 10 | SM00382 |
| Domain | Na_trans_cytopl | 6.11e-05 | 6 | 275 | 3 | IPR024583 | |
| Domain | Na_trans_cytopl | 6.11e-05 | 6 | 275 | 3 | PF11933 | |
| Domain | DHC_N1 | 1.67e-04 | 8 | 275 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.67e-04 | 8 | 275 | 3 | IPR013594 | |
| Domain | ATM/Tel1 | 2.16e-04 | 2 | 275 | 2 | IPR015519 | |
| Domain | Na_channel_asu | 3.51e-04 | 10 | 275 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 3.51e-04 | 10 | 275 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 3.51e-04 | 10 | 275 | 3 | PF06512 | |
| Domain | Ferlin_A-domain | 6.42e-04 | 3 | 275 | 2 | IPR012560 | |
| Domain | FerA | 6.42e-04 | 3 | 275 | 2 | PF08165 | |
| Domain | VDCC_T_a1 | 6.42e-04 | 3 | 275 | 2 | IPR005445 | |
| Domain | FerA | 6.42e-04 | 3 | 275 | 2 | SM01200 | |
| Domain | Niban-like | 6.42e-04 | 3 | 275 | 2 | IPR026088 | |
| Domain | ARM-like | MON2 SMG1 MROH5 CLASP2 USP9Y NIPBL MED12 PPP4R1 CLASP1 WDFY4 IPO9 PPP2R5E | 6.95e-04 | 270 | 275 | 12 | IPR011989 |
| Domain | Alkaline_phosphatase_core | 1.06e-03 | 31 | 275 | 4 | IPR017850 | |
| Domain | Alkaline_Pase-like_a/b/a | 1.06e-03 | 31 | 275 | 4 | IPR017849 | |
| Domain | - | 1.06e-03 | 31 | 275 | 4 | 3.40.720.10 | |
| Domain | Thioredoxin | 1.06e-03 | 31 | 275 | 4 | PF00085 | |
| Domain | IQ | 1.24e-03 | 81 | 275 | 6 | SM00015 | |
| Domain | DUF2012 | 1.27e-03 | 4 | 275 | 2 | PF09430 | |
| Domain | DUF2012 | 1.27e-03 | 4 | 275 | 2 | IPR019008 | |
| Domain | Peroxin/Ferlin | 1.27e-03 | 4 | 275 | 2 | IPR006614 | |
| Domain | CLASP_N | 1.27e-03 | 4 | 275 | 2 | PF12348 | |
| Domain | CLASP_N_dom | 1.27e-03 | 4 | 275 | 2 | IPR024395 | |
| Domain | DysFC | 1.27e-03 | 4 | 275 | 2 | SM00694 | |
| Domain | DysFN | 1.27e-03 | 4 | 275 | 2 | SM00693 | |
| Domain | Ion_trans_dom | 1.50e-03 | 114 | 275 | 7 | IPR005821 | |
| Domain | Ion_trans | 1.50e-03 | 114 | 275 | 7 | PF00520 | |
| Domain | - | DDX59 MYO7A ABCA13 AK9 ABCA7 DNAH14 ABCC8 GNAS DNAH5 DNAH6 DYNC1H1 ARL14 DYNC1LI2 WSCD1 DNAH3 RHOBTB3 FIGN DNAH1 IQCA1 SAR1B DHX32 DNAH11 | 1.62e-03 | 746 | 275 | 22 | 3.40.50.300 |
| Domain | - | MON2 MROH5 CLASP2 NIPBL MED12 PPP4R1 CLASP1 WDFY4 IPO9 PPP2R5E | 1.73e-03 | 222 | 275 | 10 | 1.25.10.10 |
| Domain | P-loop_NTPase | DDX59 MYO7A ABCA13 AK9 ABCA7 DNAH14 ABCC8 GNAS CAMTA1 DNAH5 DNAH6 DYNC1H1 ARL14 DYNC1LI2 WSCD1 DNAH3 RHOBTB3 FIGN DNAH1 IQCA1 SAR1B DHX32 KIF18B DNAH11 | 1.74e-03 | 848 | 275 | 24 | IPR027417 |
| Domain | A/G_cyclase_CS | 1.84e-03 | 17 | 275 | 3 | IPR018297 | |
| Domain | SULFATASE_2 | 1.84e-03 | 17 | 275 | 3 | PS00149 | |
| Domain | SULFATASE_1 | 1.84e-03 | 17 | 275 | 3 | PS00523 | |
| Domain | Ferlin_B-domain | 2.10e-03 | 5 | 275 | 2 | IPR012561 | |
| Domain | Ferlin_C | 2.10e-03 | 5 | 275 | 2 | PF16165 | |
| Domain | Glyco_hydro_38_C | 2.10e-03 | 5 | 275 | 2 | IPR011682 | |
| Domain | FerIin_dom | 2.10e-03 | 5 | 275 | 2 | IPR012968 | |
| Domain | FerI | 2.10e-03 | 5 | 275 | 2 | PF08151 | |
| Domain | FerB | 2.10e-03 | 5 | 275 | 2 | PF08150 | |
| Domain | Glyco_hydro_57/38_cen | 2.10e-03 | 5 | 275 | 2 | IPR028995 | |
| Domain | Glyco_hydro_38 | 2.10e-03 | 5 | 275 | 2 | PF01074 | |
| Domain | - | 2.10e-03 | 5 | 275 | 2 | 1.20.1270.50 | |
| Domain | Alpha-mann_mid | 2.10e-03 | 5 | 275 | 2 | SM00872 | |
| Domain | Glyco_hydro_38C | 2.10e-03 | 5 | 275 | 2 | PF07748 | |
| Domain | FerI | 2.10e-03 | 5 | 275 | 2 | SM01202 | |
| Domain | FerB | 2.10e-03 | 5 | 275 | 2 | SM01201 | |
| Domain | Ferlin_C | 2.10e-03 | 5 | 275 | 2 | IPR032362 | |
| Domain | Alpha-mann_mid | 2.10e-03 | 5 | 275 | 2 | PF09261 | |
| Domain | Cyt_P450_E_grp-II | 2.10e-03 | 5 | 275 | 2 | IPR002402 | |
| Domain | - | 2.10e-03 | 5 | 275 | 2 | 3.20.110.10 | |
| Domain | Glyco_hydro_38_N | 2.10e-03 | 5 | 275 | 2 | IPR000602 | |
| Domain | Glyco_hydro_38/57_N | 2.10e-03 | 5 | 275 | 2 | IPR027291 | |
| Domain | FATC | 2.10e-03 | 5 | 275 | 2 | PF02260 | |
| Domain | Glyco_hydro_38_cen | 2.10e-03 | 5 | 275 | 2 | IPR015341 | |
| Domain | IQ_motif_EF-hand-BS | 2.14e-03 | 90 | 275 | 6 | IPR000048 | |
| Domain | Sulfatase_N | 2.19e-03 | 18 | 275 | 3 | IPR000917 | |
| Domain | Nucleotide_cyclase | 2.19e-03 | 18 | 275 | 3 | IPR029787 | |
| Domain | Sulfatase | 2.19e-03 | 18 | 275 | 3 | PF00884 | |
| Domain | - | 2.19e-03 | 18 | 275 | 3 | 3.30.70.1230 | |
| Domain | LAM_G_DOMAIN | 2.29e-03 | 38 | 275 | 4 | PS50025 | |
| Domain | IQ | 2.52e-03 | 93 | 275 | 6 | PS50096 | |
| Domain | Guanylate_cyc | 2.57e-03 | 19 | 275 | 3 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 2.57e-03 | 19 | 275 | 3 | PS50125 | |
| Domain | A/G_cyclase | 2.57e-03 | 19 | 275 | 3 | IPR001054 | |
| Domain | PRAME_family | 2.57e-03 | 19 | 275 | 3 | IPR026271 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 3.03e-05 | 27 | 195 | 5 | M47755 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | TAAR2 GPR83 P2RY8 GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 NR3C1 GRM5 OPRK1 LHCGR | 1.07e-04 | 272 | 195 | 13 | M13380 |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 1.07e-04 | 55 | 195 | 6 | M27001 | |
| Pathway | BIOCARTA_LIS1_PATHWAY | 1.17e-04 | 19 | 195 | 4 | M22005 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | ADCY2 LIN7A CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 SLC1A6 | 1.72e-04 | 211 | 195 | 11 | MM14502 |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 2.14e-04 | 22 | 195 | 4 | M39795 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | ADCY2 LIN7A ABCC8 CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 GRM5 KCNK7 SLC1A6 | 2.38e-04 | 335 | 195 | 14 | MM14503 |
| Pathway | WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION | 2.41e-04 | 41 | 195 | 5 | M39655 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 2.56e-04 | 23 | 195 | 4 | M47666 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 2.91e-04 | 10 | 195 | 3 | M10272 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 3.02e-04 | 43 | 195 | 5 | M47669 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 3.58e-04 | 25 | 195 | 4 | M47948 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 3.75e-04 | 45 | 195 | 5 | M47670 | |
| Pubmed | Expression of glutamate receptor subunit genes during development of the mouse retina. | 2.03e-11 | 9 | 278 | 6 | 9051806 | |
| Pubmed | MON2 NCKAP1 PPRC1 DNAJC6 ADCY2 USP19 FOCAD CRACD FBXO28 CACNA1H CAMTA1 DYNC1H1 PLXNB3 CLASP1 ZSWIM6 EPG5 PPP2R5E SEC24C MACF1 SENP7 | 1.44e-10 | 407 | 278 | 20 | 12693553 | |
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 5.96e-10 | 24 | 278 | 7 | 35746896 | |
| Pubmed | 7.03e-10 | 14 | 278 | 6 | 9373155 | ||
| Pubmed | 4.23e-09 | 18 | 278 | 6 | 14730302 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ACACB NCKAP1 MAP2 MYO7A PTPN22 CLASP2 AK9 USP9Y TTC19 DNAJC10 APEX2 TAPBP MED12 RIC1 CLASP1 MAP1S VPS35 ATM USP39 CTTN | 4.50e-09 | 497 | 278 | 20 | 36774506 |
| Pubmed | SMG1 NCOA6 MAN2B1 MCAM ZNF518A DST TSEN15 DYNC1H1 MRI1 E4F1 NIBAN2 EPG5 USP5 LIMK2 PPP2R5E CTR9 CSPG4 VPS35 MACF1 PAPPA NOMO3 | 1.60e-08 | 591 | 278 | 21 | 15231748 | |
| Pubmed | 1.99e-08 | 5 | 278 | 4 | 9466455 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYO7A LAMA1 CSMD2 TMEM132B DNAH14 FOCAD FREM2 URB1 DST AGL VPS13A SCN8A DYNC1H1 PLXNB3 DNAH3 FAT4 SPAG9 GRIK5 GLIPR1L2 IGSF9B NUP188 ATM USP39 | 3.46e-08 | 736 | 278 | 23 | 29676528 |
| Pubmed | Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. | 3.84e-08 | 13 | 278 | 5 | 20859245 | |
| Pubmed | RALGAPA1 SMG1 NCOA6 PIEZO1 DST USP38 OSBPL5 ANKIB1 CACNA1G FLRT3 TMX3 ADGRL2 KCNT1 RHOBTB3 NPLOC4 INTS5 RALGPS1 NUP188 PADI2 | 6.65e-08 | 529 | 278 | 19 | 14621295 | |
| Pubmed | 6.77e-08 | 45 | 278 | 7 | 25979088 | ||
| Pubmed | 9.25e-08 | 47 | 278 | 7 | 8812413 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | MON2 EYA2 DNAJC6 LIN7A DNAJC10 AGL TXNDC16 TTC13 UQCRC2 GNAS FAR1 TMX3 PIPSL ADGRL2 CUL2 CLASP1 SPAG9 PTPRU NPLOC4 USP5 CTR9 VPS35 NUP188 CTTN PADI2 VPS29 | 9.87e-08 | 974 | 278 | 26 | 28675297 |
| Pubmed | Glutamate receptors in cortical plasticity: molecular and cellular biology. | 1.37e-07 | 7 | 278 | 4 | 9016303 | |
| Pubmed | 1.37e-07 | 7 | 278 | 4 | 9256245 | ||
| Pubmed | Glutamate receptors: brain function and signal transduction. | 1.37e-07 | 7 | 278 | 4 | 9651535 | |
| Pubmed | 1.37e-07 | 7 | 278 | 4 | 1310861 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | MAN2A1 MAN2B1 ARSK PIEZO1 LAMA1 MCAM WLS ABCA7 USP19 RINT1 MIA2 DNAJC10 NOMO2 FBXO28 SLC5A6 TXNDC16 TTC13 TMX3 TAPBP FAT4 TXNDC11 MYOF USP5 SEC24C CSPG4 VPS35 ATM STOM ATP6V0A2 | 1.46e-07 | 1201 | 278 | 29 | 35696571 |
| Pubmed | 2.73e-07 | 8 | 278 | 4 | 19125103 | ||
| Pubmed | 2.93e-07 | 81 | 278 | 8 | 22723691 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 NCOA6 MAN2B1 MYO7A PPRC1 PIEZO1 CLASP2 LYST ABCA7 FOCAD URB1 DST SCN5A OSBPL5 SCN8A CACNA1H MED12 DYNC1H1 RIC1 BICRA MLLT10 MYOF INTS5 MAP1S RALGPS1 CSPG4 NUP188 | 3.19e-07 | 1105 | 278 | 27 | 35748872 |
| Pubmed | UBR1 SMG1 MAN2B1 WLS FREM2 RINT1 DST DNAJC10 ANKIB1 UQCRC2 PZP RIC1 PPP4R1 CUL2 RHOBTB3 PATL1 NR3C1 NPLOC4 CTR9 ZBED1 | 3.55e-07 | 650 | 278 | 20 | 38777146 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NCOA6 ACACB PTPN22 LMTK3 TMEM132C MIA2 SCN1A CAMTA1 DYNC1H1 RIC1 DOCK1 BICRA MLLT10 MAP1S IGSF9B ATM | 4.64e-07 | 430 | 278 | 16 | 35044719 |
| Pubmed | 4.88e-07 | 9 | 278 | 4 | 16382099 | ||
| Pubmed | 5.05e-07 | 3 | 278 | 3 | 19217372 | ||
| Pubmed | 5.05e-07 | 3 | 278 | 3 | 12172541 | ||
| Pubmed | 5.05e-07 | 3 | 278 | 3 | 16325263 | ||
| Pubmed | NCKAP1 CLASP2 LMTK3 DNAJC6 TMEM132B DST NIPBL KCNT1 DYNC1H1 TBL1X CACNA1A CACNA1E CLASP1 GRIA1 GRIA3 GRIA4 GRIK3 GRIK5 PEX5L GRM5 SEC24C FAM171A2 MACF1 CTTN | 1.06e-06 | 963 | 278 | 24 | 28671696 | |
| Pubmed | MON2 ZSWIM8 BPIFB1 ABCA7 ZNF518A TAF8 DNAJC10 SCN5A TAF1 FAR1 TMX3 TAF10 ADGRL2 PHIP ALPL BICRA RHOBTB3 LIMK2 ZNF24 PPP2R5E RESF1 MACF1 NUP188 KIF18B PADI2 SENP7 | 1.29e-06 | 1116 | 278 | 26 | 31753913 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | MON2 PRAMEF5 ZNF274 MCAM USP19 CRACD DST CACNA1G PRAMEF6 COL6A3 PRAMEF12 NR3C1 MYOF SENP7 | 1.61e-06 | 363 | 278 | 14 | 14691545 |
| Pubmed | Exome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian disorders. | 1.83e-06 | 72 | 278 | 7 | 25917818 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | ABCC8 SCN1A SCN5A SCN8A CACNA1H CACNA1G CACNA1A CACNA1E KCNK7 | 1.94e-06 | 139 | 278 | 9 | 16985003 |
| Pubmed | Distribution of kainate receptor subunits at hippocampal mossy fiber synapses. | 2.01e-06 | 4 | 278 | 3 | 12954862 | |
| Pubmed | AMPA receptor subunits expressed by single astrocytes in the juvenile mouse hippocampus. | 2.01e-06 | 4 | 278 | 3 | 9221927 | |
| Pubmed | Interaction proteomics reveals brain region-specific AMPA receptor complexes. | 2.01e-06 | 4 | 278 | 3 | 25337787 | |
| Pubmed | Auditory sensitivity regulation via rapid changes in expression of surface AMPA receptors. | 2.01e-06 | 4 | 278 | 3 | 17828255 | |
| Pubmed | AMPA receptors regulate dynamic equilibrium of presynaptic terminals in mature hippocampal networks. | 2.01e-06 | 4 | 278 | 3 | 12692557 | |
| Pubmed | 2.01e-06 | 4 | 278 | 3 | 19657020 | ||
| Pubmed | 2.01e-06 | 4 | 278 | 3 | 14561864 | ||
| Pubmed | Cortactin regulates endo-lysosomal sorting of AMPARs via direct interaction with GluA2 subunit. | 2.01e-06 | 4 | 278 | 3 | 29515177 | |
| Pubmed | 2.01e-06 | 4 | 278 | 3 | 31800012 | ||
| Pubmed | 2.01e-06 | 4 | 278 | 3 | 24652293 | ||
| Pubmed | Mutations in dynein genes in patients affected by isolated non-syndromic asthenozoospermia. | 2.01e-06 | 4 | 278 | 3 | 18492703 | |
| Pubmed | 2.01e-06 | 4 | 278 | 3 | 12125045 | ||
| Pubmed | 2.01e-06 | 4 | 278 | 3 | 10688364 | ||
| Pubmed | 2.01e-06 | 4 | 278 | 3 | 17409242 | ||
| Pubmed | 2.01e-06 | 4 | 278 | 3 | 1319477 | ||
| Pubmed | Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculature. | 2.01e-06 | 4 | 278 | 3 | 21788606 | |
| Pubmed | 2.01e-06 | 4 | 278 | 3 | 9648857 | ||
| Pubmed | PRAMEF5 PPRC1 CLASP2 WLS URB1 GFPT2 CAMTA1 TMX3 TAPBP PRAMEF6 DYNC1LI2 POLD2 MARCHF7 PRAMEF12 PATL1 WDFY4 CD160 ZNF24 PPP2R5E RESF1 SEC24C CTR9 MACF1 NUP188 ATP6V0A2 | 2.49e-06 | 1084 | 278 | 25 | 11544199 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | SMG1 ZSWIM8 ABCA13 PIEZO1 LYST FREM2 VPS13A TAF1 GNAS PHIP CACNA1A GRIK3 ZSWIM6 TBC1D8 IGSF9B NOMO3 DNAH11 | 2.70e-06 | 552 | 278 | 17 | 10737800 |
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | SMG1 CLASP2 DNAJC6 USP38 DYNC1LI2 CLASP1 PEX5L CCNT2 LIMK2 SAR1B | 2.81e-06 | 186 | 278 | 10 | 33637726 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 PDE9A MAP2 CLASP2 ATP8B1 EIPR1 DNAH14 TTC19 ABCC8 OSBPL5 ANKIB1 CACNA1H GNAS CAMTA1 TMX3 TSEN15 VAV2 RIC1 TBL1X DOCK1 BICRA PATL1 ZSWIM6 NPLOC4 DNAH1 ASMTL RALGPS1 MACF1 IGSF9B KLHL26 | 3.68e-06 | 1489 | 278 | 30 | 28611215 |
| Pubmed | From the Cover: Indispensability of the glutamate transporters GLAST and GLT1 to brain development. | 3.75e-06 | 14 | 278 | 4 | 16880397 | |
| Pubmed | 4.99e-06 | 5 | 278 | 3 | 18358623 | ||
| Pubmed | Development of laminar distributions of kainate receptors in the somatosensory cortex of mice. | 4.99e-06 | 5 | 278 | 3 | 9593973 | |
| Pubmed | 4.99e-06 | 5 | 278 | 3 | 8288598 | ||
| Pubmed | Developmental expression patterns of kainate receptors in the mouse spinal cord. | 4.99e-06 | 5 | 278 | 3 | 23076118 | |
| Pubmed | Role of CLASP2 in microtubule stabilization and the regulation of persistent motility. | 4.99e-06 | 5 | 278 | 3 | 17113391 | |
| Pubmed | 4.99e-06 | 5 | 278 | 3 | 16129400 | ||
| Pubmed | 4.99e-06 | 5 | 278 | 3 | 26448475 | ||
| Pubmed | Kainate receptors: pharmacology, function and therapeutic potential. | 4.99e-06 | 5 | 278 | 3 | 18793656 | |
| Pubmed | 4.99e-06 | 5 | 278 | 3 | 12223554 | ||
| Pubmed | 4.99e-06 | 5 | 278 | 3 | 29088312 | ||
| Pubmed | 4.99e-06 | 5 | 278 | 3 | 28228252 | ||
| Pubmed | ZSWIM8 is a myogenic protein that partly prevents C2C12 differentiation. | 4.99e-06 | 5 | 278 | 3 | 34686700 | |
| Pubmed | 4.99e-06 | 5 | 278 | 3 | 9482932 | ||
| Pubmed | 4.99e-06 | 5 | 278 | 3 | 12060068 | ||
| Pubmed | Preferential assembly of heteromeric kainate and AMPA receptor amino terminal domains. | 4.99e-06 | 5 | 278 | 3 | 29058671 | |
| Pubmed | ZSWIM8 RELN PDE9A GAMT PPRC1 USP9Y FOCAD DST MIA2 NOMO2 TAF1 GFPT2 NIPBL DYNC1H1 PLXNB3 ALPL PPP4R1 RHOBTB3 IDS TXNDC11 PPP2R5E MAP1S CTR9 MACF1 ATM CTTN PADI2 | 5.46e-06 | 1285 | 278 | 27 | 35914814 | |
| Pubmed | RELN GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 NR3C1 GRM5 SLC1A6 OPRK1 LHCGR | 6.21e-06 | 300 | 278 | 12 | 19086053 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | MON2 PRPSAP1 MAN2B1 NCKAP1 MAP2 USP19 AGL DYNC1H1 DYNC1LI2 PPP4R1 CUL2 NIBAN1 POLD2 SPAG9 NIBAN2 NR3C1 NPLOC4 USP5 IPO9 PPP2R5E SEC24C MAP1S CTR9 ASMTL VPS35 MACF1 NUP188 CTTN VPS29 | 6.63e-06 | 1455 | 278 | 29 | 22863883 |
| Pubmed | 6.74e-06 | 16 | 278 | 4 | 16880404 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | MON2 ZSWIM8 LAMA1 DNAJC10 ANKIB1 GNAS RHOBTB3 USP5 IPO9 ATM STOM ATP6V0A2 | 9.52e-06 | 313 | 278 | 12 | 38270169 |
| Pubmed | 9.93e-06 | 6 | 278 | 3 | 18922769 | ||
| Pubmed | N-glycan content modulates kainate receptor functional properties. | 9.93e-06 | 6 | 278 | 3 | 28714086 | |
| Pubmed | RALGAPA1 MAP2 PIEZO1 CLASP2 DNAJC6 RINT1 URB1 DNAJC10 NOMO2 VPS13A TTC13 UQCRC2 GNAS FAR1 TMX3 ADGRL2 CUL2 NIBAN2 NR3C1 TBC1D8 SEC24C FAM171A2 BBS7 CTR9 VPS35 MACF1 ATM STOM ATP6V0A2 | 9.98e-06 | 1487 | 278 | 29 | 33957083 | |
| Pubmed | 1.50e-05 | 225 | 278 | 10 | 12168954 | ||
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 1.64e-05 | 67 | 278 | 6 | 21875946 | |
| Pubmed | 1.73e-05 | 7 | 278 | 3 | 19342380 | ||
| Pubmed | 1.73e-05 | 7 | 278 | 3 | 21368048 | ||
| Pubmed | 1.73e-05 | 7 | 278 | 3 | 17428973 | ||
| Pubmed | Hippocampal AMPA receptor assemblies and mechanism of allosteric inhibition. | 1.73e-05 | 7 | 278 | 3 | 33981040 | |
| Pubmed | 1.73e-05 | 7 | 278 | 3 | 15272007 | ||
| Pubmed | 1.73e-05 | 7 | 278 | 3 | 27076426 | ||
| Pubmed | Impairment of AMPA receptor function in cerebellar granule cells of ataxic mutant mouse stargazer. | 1.73e-05 | 7 | 278 | 3 | 10407040 | |
| Pubmed | 1.73e-05 | 7 | 278 | 3 | 12900400 | ||
| Pubmed | STAGA recruits Mediator to the MYC oncoprotein to stimulate transcription and cell proliferation. | 1.75e-05 | 20 | 278 | 4 | 17967894 | |
| Pubmed | SMG1 NCOA6 ACACB MYO7A CSMD2 ADCY2 VPS13A GFPT2 FER1L5 NIPBL FAT4 NR3C1 IPO9 BBS7 USP39 NOMO3 DNAH11 | 1.77e-05 | 638 | 278 | 17 | 31182584 | |
| Pubmed | 2.10e-05 | 234 | 278 | 10 | 36243803 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | BPIFB1 CLASP2 HAUS8 RINT1 URB1 FBXO28 GNAS HSF2 TSEN15 NIPBL DYNC1H1 DYNC1LI2 CLASP1 TROAP SPAG9 NIBAN2 PATL1 TERF2 PPP2R5E MAP1S NUP188 ATM USP39 STOM | 2.22e-05 | 1155 | 278 | 24 | 20360068 |
| Pubmed | MAP2 LMTK3 DNAJC6 DST DYNC1LI2 CACNA1A CACNA1E BCAN PEX5L VPS35 MACF1 CTTN | 2.64e-05 | 347 | 278 | 12 | 17114649 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | NCKAP1 WLS USP19 RINT1 URB1 TTC13 FAR1 TMX3 ADGRL2 TAPBP DYNC1H1 MARCHF7 USP5 INTS5 IPO9 PPP2R5E FAM171A2 VPS35 NUP188 NOMO3 STOM | 2.68e-05 | 942 | 278 | 21 | 31073040 |
| Pubmed | MON2 DDX59 CYP3A5 CLASP2 EIPR1 USP19 CENPP CRACD NIPBL MED12 ARL14 REC8 PPP4R1 BICRA MARCHF7 PATL1 ZSWIM6 CCNT2 SLC22A9 IPO9 PPP2R5E MTF1 CTR9 VPS35 NUP188 ATP6V0A2 | 2.72e-05 | 1327 | 278 | 26 | 32694731 | |
| Pubmed | Synaptic profiles during neurite extension, refinement and retraction in the developing cochlea. | 2.75e-05 | 8 | 278 | 3 | 23217150 | |
| Pubmed | 2.75e-05 | 8 | 278 | 3 | 28330839 | ||
| Pubmed | Transmembrane topology of the glutamate receptor subunit GluR6. | 2.75e-05 | 8 | 278 | 3 | 8163463 | |
| Pubmed | Hippocampal AMPA receptor gating controlled by both TARP and cornichon proteins. | 2.75e-05 | 8 | 278 | 3 | 21172611 | |
| Pubmed | 3.14e-05 | 23 | 278 | 4 | 8464923 | ||
| Interaction | TAF2 interactions | AK9 RINT1 TAF8 TAF1 TAF10 PHIP NR3C1 TERF2 CCNT2 INTS5 ELF4 CTTN | 4.90e-06 | 178 | 268 | 12 | int:TAF2 |
| Cytoband | 9q33.2 | 9.03e-05 | 39 | 277 | 4 | 9q33.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q33 | 2.02e-04 | 138 | 277 | 6 | chr9q33 | |
| Cytoband | Xp22.3 | 3.52e-04 | 23 | 277 | 3 | Xp22.3 | |
| GeneFamily | Dyneins, axonemal | 2.02e-08 | 17 | 202 | 6 | 536 | |
| GeneFamily | Glutamate ionotropic receptor AMPA type subunits | 5.45e-06 | 4 | 202 | 3 | 1200 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 1.35e-05 | 5 | 202 | 3 | 1199 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.10e-04 | 9 | 202 | 3 | 1203 | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.86e-04 | 26 | 202 | 4 | 253 | |
| GeneFamily | Ubiquitin specific peptidases | 3.99e-04 | 56 | 202 | 5 | 366 | |
| GeneFamily | Sulfatases | 9.91e-04 | 18 | 202 | 3 | 410 | |
| GeneFamily | Mannosidases alpha class 2 | 1.21e-03 | 5 | 202 | 2 | 1194 | |
| GeneFamily | Ferlin family | 1.81e-03 | 6 | 202 | 2 | 828 | |
| GeneFamily | PRAME family | 2.34e-03 | 24 | 202 | 3 | 686 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 2.51e-03 | 51 | 202 | 4 | 870 | |
| GeneFamily | Guanylate cyclase receptors | 2.51e-03 | 7 | 202 | 2 | 343 | |
| GeneFamily | Pseudoautosomal region 1|Solute carriers | 2.64e-03 | 25 | 202 | 3 | 715 | |
| GeneFamily | EF-hand domain containing|Plakins | 3.33e-03 | 8 | 202 | 2 | 939 | |
| GeneFamily | Cytochrome P450 family 3 | 3.33e-03 | 8 | 202 | 2 | 1002 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.76e-03 | 57 | 202 | 4 | 1179 | |
| GeneFamily | Zinc fingers SWIM-type|Mitogen-activated protein kinase kinase kinases | 4.25e-03 | 9 | 202 | 2 | 90 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 4.25e-03 | 9 | 202 | 2 | 1230 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_NKCELL_DN | MON2 ZSWIM8 CLASP2 LYST ADCY2 NIPBL TBL1X CLASP1 RHOBTB3 ATP10D SEC24C MACF1 ELF4 | 1.78e-07 | 198 | 273 | 13 | M4415 |
| Coexpression | GSE2128_C57BL6_VS_NOD_THYMOCYTE_DN | ACAP1 NCKAP1 PIEZO1 ABCA7 APEX2 FBXO28 SRPX RIC1 BCAN NIBAN2 RLN1 LHCGR | 1.38e-06 | 200 | 273 | 12 | M6187 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | RELN MAP2 MYO7A FAM114A2 CSMD2 DNAJC6 LYST TMEM132B PXK FSIP2 FAT2 SCN1A SCN8A ANKIB1 CACNA1G CAMTA1 VAV2 ZNF697 CACNA1A CACNA1E GRIA1 GRIA4 GRIK3 IDS PEX5L GRM5 LRRN3 RALGPS1 PAPPA IGSF9B | 1.83e-06 | 1106 | 273 | 30 | M39071 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | PCSK2 PDE1C RELN MAP2 CLASP2 LMTK3 CSMD2 DNAJC6 TMEM132B ADCY2 SCN8A ZNF697 CACNA1E FAT4 GRIA3 GRIK3 ZSWIM6 OPRK1 RALGPS1 PAPPA | 3.76e-06 | 584 | 273 | 20 | M39068 |
| Coexpression | MURARO_PANCREAS_PANCREATIC_POLYPEPTIDE_CELL | MAP2 PXK ABCC8 CACNA1H GNAS ADGRL2 CACNA1A RHOBTB3 GRIA3 IDS | 4.95e-06 | 153 | 273 | 10 | M39171 |
| Coexpression | GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN | NCOA6 MAN2A1 PPRC1 PTPN22 LIN7A SCN5A DYNC1H1 NR3C1 TERF2 VPS35 STOM | 7.96e-06 | 198 | 273 | 11 | M3242 |
| Coexpression | GSE3982_MAC_VS_NKCELL_DN | PCSK2 CACNA1G TAF1 HSF2 XKR8 E4F1 MLLT10 RLN1 ELF4 IGSF9B USP39 | 7.96e-06 | 198 | 273 | 11 | M5509 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2C | PDE1C RELN LAMA1 CSMD2 SCN1A DNAH6 DOCK1 WSCD1 GRIA1 BCAN GRM5 IQCA1 DHX32 IGSF9B | 9.01e-06 | 325 | 273 | 14 | M39053 |
| Coexpression | JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP | MAN2A1 PIEZO1 VPS13A SRPX ACKR2 FLRT3 ALDH3A1 ADGRF1 DYNC1H1 ARL14 RHOBTB3 SPAG9 TXNDC11 MACF1 CTTN | 1.30e-05 | 382 | 273 | 15 | M38972 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA2 | PCSK2 MAP2 CSMD2 DNAJC6 TMEM132B ABCC8 SCN8A FLRT3 ZNF697 CACNA1A CACNA1E GRIA3 GRIK3 PEX5L GRM5 OPRK1 PAPPA | 3.08e-05 | 513 | 273 | 17 | M39069 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | PDE1C WLS ADCY2 TMEM132C FREM2 FAT2 DST SCN1A SCGB1A1 FLRT3 DNAH6 VCAM1 GRIA1 BCAN NR3C1 LRRN3 CD19 IQCA1 | 3.70e-05 | 574 | 273 | 18 | M39056 |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN | 4.45e-05 | 197 | 273 | 10 | M4421 | |
| Coexpression | GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP | 4.84e-05 | 199 | 273 | 10 | M9754 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN | NCKAP1 PIEZO1 PTPN22 GFPT2 GNAS PPP4R1 NIBAN1 NR3C1 ATP10D RALGPS1 | 5.05e-05 | 200 | 273 | 10 | M6513 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | RELN PDE9A LAMA1 MCAM ATP8B1 LIN7A GPR83 FREM2 SCN5A GNAS VAV2 ALPL DOCK1 FAT4 NIBAN1 BCAN GRIK3 PTPRU FIGN CSPG4 GUCY2D PAPPA KIF18B LY75 STOM DNAH11 | 6.33e-05 | 1074 | 273 | 26 | M1941 |
| Coexpression | GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 6.45e-05 | 166 | 273 | 9 | M9100 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | ANKRD13B RELN MAP2 LMTK3 LYST TMEM132B ADCY2 ZNF697 CACNA1E GRIA1 GRIA3 GRIA4 GRIK3 TERF2 OPRK1 PAPPA | 9.10e-05 | 506 | 273 | 16 | M39067 |
| Coexpression | HALLMARK_APICAL_SURFACE | 9.21e-05 | 44 | 273 | 5 | M5916 | |
| CoexpressionAtlas | cerebral cortex | ANKRD13B PCSK2 MAP2 CLASP2 LMTK3 CSMD2 DNAJC6 CYP46A1 TMEM132B ADCY2 GPR83 ABCC8 SCN1A SCN8A CACNA1G KCNT1 PLXNB3 CACNA1A WSCD1 CACNA1E SLC25A41 GRIA1 GRIA3 GRIA4 BCAN GRIK3 GRIK4 GRIK5 IDS FREM3 PEX5L GRM5 SLC1A6 OPRK1 SYT16 LRRN3 FAM171A2 TMEM132E PADI2 | 3.94e-06 | 1428 | 267 | 39 | cerebral cortex |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | RALGAPA1 PDE1C CLASP2 ATP8B1 ADCY2 LIN7A CENPP DST AGL VPS13A ANKIB1 L3HYPDH SRPX FLRT3 FAR1 DOCK1 COL6A3 FAT4 RHOBTB3 GRIA4 NR3C1 IDS CCNT2 VPS35 PAPPA | 1.61e-05 | 772 | 267 | 25 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PDE1C RELN ABCA13 LAMA1 FREM2 DNAH5 FAT4 MUC5B GRIK3 FIGN DNAH1 GUCY2F DNAH11 | 1.56e-10 | 184 | 277 | 13 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PDE1C RELN ABCA13 LAMA1 FREM2 DNAH5 FAT4 MUC5B GRIK3 FIGN DNAH1 GUCY2F DNAH11 | 1.56e-10 | 184 | 277 | 13 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PDE1C RELN ABCA13 LAMA1 FREM2 DNAH5 FAT4 MUC5B GRIK3 FIGN DNAH1 GUCY2F DNAH11 | 1.56e-10 | 184 | 277 | 13 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | MAP2 TMEM132B ADCY2 FOCAD SCN1A SCN8A ADGRL2 CACNA1A GRIA1 IDS GRM5 SYT16 | 4.57e-09 | 198 | 277 | 12 | c01091ef18e096d792ea2a7a715764a5b215355f |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | MAP2 TMEM132B FOCAD SCN1A SCN8A ADGRL2 CACNA1A GRIA1 GRIA3 IDS GRM5 SYT16 | 4.57e-09 | 198 | 277 | 12 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | MAP2 TMEM132B FOCAD SCN1A SCN8A ADGRL2 CACNA1A GRIA1 GRIA3 IDS GRM5 SYT16 | 4.57e-09 | 198 | 277 | 12 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | NCKAP1 ABCA13 LAMA1 CSMD2 DNAH14 LIN7A ABCC8 ALPL CACNA1A NIBAN1 OPRK1 | 4.24e-08 | 195 | 277 | 11 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | NCKAP1 ABCA13 LAMA1 CSMD2 DNAH14 LIN7A ABCC8 ALPL CACNA1A NIBAN1 OPRK1 | 4.24e-08 | 195 | 277 | 11 | d3755929ebbbf5e3afde44281e9056ddb614a291 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | PCSK2 MAP2 TMEM132B FOCAD SCN8A ADGRL2 GRIA1 GRIA3 IDS GRM5 SYT16 | 4.46e-08 | 196 | 277 | 11 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ADCY2 FREM2 SCGB1A1 ADGRF1 DNAH5 DNAH3 MUC5B DNAH1 SLC9A4 DNAH11 | 8.48e-08 | 164 | 277 | 10 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.34e-07 | 190 | 277 | 10 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | NCOA6 TAF8 FBXO28 ANKIB1 ELAC1 CUL2 TERF2 SEC24C TMEM100 ATP6V0A2 | 3.51e-07 | 191 | 277 | 10 | 39ef8e1d7cc3ebb11717e8a55501515e3b72b177 |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ABCA13 FAM83E BPIFB1 EYA2 ABCA7 ADCY2 URB1 MUC5B LIMK2 FAM171A2 | 4.05e-07 | 194 | 277 | 10 | e0228f593c3493175962a4817500d4337ddc4e88 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | TMEM132B TMEM132C SCN1A CACNA1A WSCD1 GRIA3 BCAN GRM5 CSPG4 IGSF9B | 4.45e-07 | 196 | 277 | 10 | f374cb3ec31c6eef2cef9e07547bfd1e380553af |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | TMEM132B TMEM132C SCN1A CACNA1A WSCD1 GRIA3 BCAN GRM5 CSPG4 IGSF9B | 4.45e-07 | 196 | 277 | 10 | 671c380b58d7f634b4fbec38c357d357ea4f3535 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.66e-07 | 197 | 277 | 10 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Bronchus_Control_(B.)-Endothelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | PCSK2 BAAT MCAM DST CACNA1H FLRT3 WSCD1 SLC25A41 GRIK3 SYT16 | 4.88e-07 | 198 | 277 | 10 | feac39036b5c0ab97b524cc366286942d136d42f |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | DST ADGRL2 VCAM1 COL6A3 FAT4 RHOBTB3 TDO2 FIGN PAPPA TMEM100 | 5.11e-07 | 199 | 277 | 10 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 5.35e-07 | 200 | 277 | 10 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.35e-07 | 200 | 277 | 10 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.35e-07 | 200 | 277 | 10 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.42e-07 | 154 | 277 | 9 | 30cb4bb297fa815adb829f3b5cafca56fcbcb810 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.42e-07 | 154 | 277 | 9 | 42bd8f88fd075a2d4edde394785decad88a2660a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.42e-07 | 154 | 277 | 9 | 6425d9861148586466febd6eceae1b1f9b9a14c1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.42e-07 | 154 | 277 | 9 | ade094e2947761a0a34daa8fcff3e9ea8437e4a5 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.73e-07 | 155 | 277 | 9 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.73e-07 | 155 | 277 | 9 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.12e-06 | 168 | 277 | 9 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-06 | 169 | 277 | 9 | 8c96e1baa38ec5e777e627ab9dbce025e771f2c0 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.18e-06 | 169 | 277 | 9 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-06 | 169 | 277 | 9 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells-Airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-06 | 169 | 277 | 9 | 86041be5d3aeab5b9269f7912791b944f325a1b4 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.18e-06 | 169 | 277 | 9 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-06 | 169 | 277 | 9 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | TCGA-Brain|World / Sample_Type by Project: Shred V9 | 1.24e-06 | 170 | 277 | 9 | f78e360a6a44d599ec0d207cba4704e50aa314f8 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.58e-06 | 175 | 277 | 9 | bbce8b1a160b414c0bf643c21c4e5e78fbccb7e1 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma-schwann_cells|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.58e-06 | 175 | 277 | 9 | 8b010220cdfb680ec839572f4933adfb85045ea6 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.58e-06 | 175 | 277 | 9 | 0b579aeadcc06be83627391c0b01bd8605fdbdf3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.65e-06 | 176 | 277 | 9 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 1.65e-06 | 176 | 277 | 9 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.90e-06 | 179 | 277 | 9 | 53e700494d251ec5649b2dea5fc7d5aeeeed572b | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-06 | 182 | 277 | 9 | c84f44391932080df31c8765e363c3dff64b2bd1 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crhr2_Efemp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.22e-06 | 136 | 277 | 8 | e3a2425ba5ef538dbacab1479e682837ae42a888 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.28e-06 | 183 | 277 | 9 | 5377b4fbd8fdfe68933b4c0965aa9525f7f31591 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 2.39e-06 | 184 | 277 | 9 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.72e-06 | 187 | 277 | 9 | e04fb35f2f5b120659d06b5ae427ab1ec56d5c36 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-06 | 188 | 277 | 9 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-06 | 188 | 277 | 9 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADCY2 TMEM132C CACNA1G SRPX GFPT2 DNAH6 COL6A3 PCDHB11 GRIA3 | 2.97e-06 | 189 | 277 | 9 | 29287525120be2953b76881ba3cfc4379c265e7a |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADCY2 TMEM132C CACNA1G SRPX GFPT2 DNAH6 COL6A3 PCDHB11 GRIA3 | 2.97e-06 | 189 | 277 | 9 | 7150dad9a92a715487c2d8130fa01b752ea69663 |
| ToppCell | facs-Skin-nan-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADCY2 TMEM132C CACNA1G SRPX GFPT2 DNAH6 COL6A3 PCDHB11 GRIA3 | 2.97e-06 | 189 | 277 | 9 | 6e4c0effd5192fd00052abc048fdb87a74fb6554 |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-06 | 189 | 277 | 9 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.10e-06 | 190 | 277 | 9 | 2434b8ad2976eab7d9147012c28454ab29670709 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.24e-06 | 191 | 277 | 9 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.38e-06 | 192 | 277 | 9 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.41e-06 | 144 | 277 | 8 | 71107275767a0728541a3695715c44874b3e5efc | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.53e-06 | 193 | 277 | 9 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-06 | 193 | 277 | 9 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | ASK440-Epithelial-Secretory|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.53e-06 | 193 | 277 | 9 | 50e98d91697c7af6a3de39e52edde6dd2b67b512 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.53e-06 | 193 | 277 | 9 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-06 | 145 | 277 | 8 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.68e-06 | 194 | 277 | 9 | 8ddcaaf24cee6e30d5be52c0cbf778cfba309c53 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.00e-06 | 196 | 277 | 9 | b07db4a53ab9be9aad6fae5e45f9547db829d096 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.00e-06 | 196 | 277 | 9 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.00e-06 | 196 | 277 | 9 | e6adcfe1a00d4910e0b92848f8a80224e0d6db12 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.00e-06 | 196 | 277 | 9 | c366f980cc04abfe1c0c14746c11810c812a42c0 | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 4.17e-06 | 197 | 277 | 9 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | Severe_COVID-19-Epithelial-transitional_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | NCKAP1 ABCA13 BPIFB1 LMTK3 SCGB1A1 ALDH3A1 ADGRF1 DNAH5 CTTN | 4.17e-06 | 197 | 277 | 9 | 5ad3cd4c77016e862041baac3076f8cc0f75c417 |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.17e-06 | 197 | 277 | 9 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.17e-06 | 197 | 277 | 9 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.17e-06 | 197 | 277 | 9 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.18e-06 | 148 | 277 | 8 | 4d43efee96a6493abd78e9ca41aab73db0c80626 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 4.34e-06 | 198 | 277 | 9 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | Bronchus_Control_(B.)-Endothelial-TX-Bronchial_vessel|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 4.34e-06 | 198 | 277 | 9 | dcf334d13e5b0018fee24febccfef91c9e17843b | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.34e-06 | 198 | 277 | 9 | 28ada093cec552262731194a04a4b9ff93186c3b | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.53e-06 | 199 | 277 | 9 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | PSB-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.53e-06 | 199 | 277 | 9 | 58dcb0eedafa8629585dc99e53147e2287f49689 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.71e-06 | 200 | 277 | 9 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1--L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.71e-06 | 200 | 277 | 9 | f3c710f0fc8a7bfb5371d1aff6e3d8f266953153 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.71e-06 | 200 | 277 | 9 | 70a06fd7fb8de2c8ec3e3182e4476ced049daeae | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.71e-06 | 200 | 277 | 9 | 1639982d9d994918f7912d12d9d7cfcbc9da4145 | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.71e-06 | 200 | 277 | 9 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.71e-06 | 200 | 277 | 9 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.71e-06 | 200 | 277 | 9 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.71e-06 | 200 | 277 | 9 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.71e-06 | 200 | 277 | 9 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.71e-06 | 200 | 277 | 9 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.71e-06 | 200 | 277 | 9 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.71e-06 | 200 | 277 | 9 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.71e-06 | 200 | 277 | 9 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.71e-06 | 200 | 277 | 9 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.09e-06 | 152 | 277 | 8 | 0652ee3443e6fbb679d2c4f326239ae7c803f924 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crhr2_Efemp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.60e-06 | 154 | 277 | 8 | a2adaa4a6cd8708cd579b8efbeb4ff2131c5482e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.88e-06 | 155 | 277 | 8 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.46e-06 | 157 | 277 | 8 | 741d79c10cb87fa7f14080c6fccb1553c3a20bad | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.77e-06 | 158 | 277 | 8 | 35f3082109a5930b89d14db3c8fa93148d3a5dd4 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 7.09e-06 | 159 | 277 | 8 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-06 | 160 | 277 | 8 | f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.77e-06 | 161 | 277 | 8 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.77e-06 | 161 | 277 | 8 | dccb61d5e17a8f1c6d1fc146ee389f567659a0f0 | |
| Drug | Ly294486 | 2.45e-10 | 9 | 276 | 6 | CID005311255 | |
| Drug | DETC-MeSO | 7.65e-10 | 39 | 276 | 9 | CID003035711 | |
| Drug | sym 2206 | 1.32e-09 | 11 | 276 | 6 | CID005039877 | |
| Drug | LY382884 | 1.59e-09 | 19 | 276 | 7 | CID000656723 | |
| Drug | Atpa | 2.61e-09 | 12 | 276 | 6 | CID000002252 | |
| Drug | 7-chlorokynurenic acid | 3.00e-09 | 45 | 276 | 9 | CID000001884 | |
| Drug | 2-amino-4-phosphonobutyric acid | ADCY2 TAF1 CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 GRM5 | 1.37e-08 | 91 | 276 | 11 | CID000002207 |
| Drug | decahydroisoquinoline | 2.17e-08 | 16 | 276 | 6 | CID000097812 | |
| Drug | LY339434 | 3.06e-08 | 9 | 276 | 5 | CID006324635 | |
| Drug | AC1NUW3V | 4.43e-08 | 29 | 276 | 7 | CID005462126 | |
| Drug | LY293558 | 5.72e-08 | 30 | 276 | 7 | CID000127894 | |
| Drug | 4-methylglutamic acid | 7.31e-08 | 31 | 276 | 7 | CID000005365 | |
| Drug | willardine | 9.26e-08 | 32 | 276 | 7 | CID000005123 | |
| Drug | IDRA 21 | 1.01e-07 | 20 | 276 | 6 | CID000003688 | |
| Drug | AC1L1B62 | 1.40e-07 | 21 | 276 | 6 | CID000001299 | |
| Drug | hexachlorophene | SLC5A6 CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 GRM5 | 1.42e-07 | 90 | 276 | 10 | CID000003598 |
| Drug | LY354740 | 1.71e-07 | 51 | 276 | 8 | CID000114827 | |
| Drug | NS 102 | 1.91e-07 | 22 | 276 | 6 | CID005282252 | |
| Drug | CX516 | 1.91e-07 | 22 | 276 | 6 | CID000148184 | |
| Drug | AC1L1EKQ | 2.00e-07 | 52 | 276 | 8 | CID000002834 | |
| Drug | Quinoxaline | 2.00e-07 | 52 | 276 | 8 | CID000007045 | |
| Drug | R,S)-AMPA | 2.20e-07 | 36 | 276 | 7 | CID000001221 | |
| Drug | riluzole | MAP2 SCN5A CACNA1H CACNA1G CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 GRM5 | 2.21e-07 | 174 | 276 | 13 | CID000005070 |
| Drug | AC1L1E5T | 2.76e-07 | 74 | 276 | 9 | CID000002653 | |
| Drug | AC1L1DME | 3.10e-07 | 75 | 276 | 9 | CID000002414 | |
| Drug | 3,4-dihydroquinazoline | 3.11e-07 | 6 | 276 | 4 | CID000583065 | |
| Drug | L-BMAA | 3.26e-07 | 38 | 276 | 7 | CID000028558 | |
| Drug | CGS 19755 | 3.26e-07 | 38 | 276 | 7 | CID000068736 | |
| Drug | GAMs | 3.26e-07 | 38 | 276 | 7 | CID000002935 | |
| Drug | CGP 39653 | 3.37e-07 | 24 | 276 | 6 | CID006437837 | |
| Drug | gamma-aminobutyric acid | RELN MAP2 VPS13A CACNA1H CACNA1G ALDH3A1 MED12 ALPL CACNA1A CACNA1E GRIA1 MARCHF7 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 GRM5 SLC1A6 OPRK1 USP39 | 3.84e-07 | 474 | 276 | 21 | CID000000119 |
| Drug | HA-966 | 3.94e-07 | 39 | 276 | 7 | CID000001232 | |
| Drug | Ns102 | 4.39e-07 | 25 | 276 | 6 | CID005311098 | |
| Drug | butylparaben | RELN LIN7A CACNA1H CACNA1G ALPL CACNA1A CACNA1E GRIA4 GRIK4 GRIK5 NR3C1 SLC1A6 | 5.08e-07 | 157 | 276 | 12 | ctd:C038091 |
| Drug | aniracetam | PPRC1 LYST VCAM1 GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 OCA2 GRIK5 GRM5 | 5.53e-07 | 130 | 276 | 11 | CID000002196 |
| Drug | 3,5-dihydroxyphenylglycine | 6.25e-07 | 60 | 276 | 8 | CID000108001 | |
| Drug | LY341495 | 7.91e-07 | 43 | 276 | 7 | CID006324636 | |
| Drug | Joro spider toxin | 7.91e-07 | 43 | 276 | 7 | CID000119582 | |
| Drug | cis-2,3-piperidine dicarboxylic acid | 1.40e-06 | 30 | 276 | 6 | CID000001226 | |
| Drug | AC1L32TU | 1.40e-06 | 30 | 276 | 6 | CID000107831 | |
| Drug | caffeine | CYP3A7 PDE1C PDE9A GAMT CYP3A5 CYP46A1 ADCY2 CACNA1H CACNA1G UQCRC2 PHIP CACNA1A CACNA1E GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 GRM5 ZNF24 ATM | 1.59e-06 | 562 | 276 | 22 | CID000002519 |
| Drug | methylenecyclopropylglycine | 1.98e-06 | 49 | 276 | 7 | CID000441452 | |
| Drug | alpha-methyl-4-carboxyphenylglycine | 2.09e-06 | 32 | 276 | 6 | CID000001222 | |
| Drug | AC1L1FA8 | 2.28e-06 | 50 | 276 | 7 | CID000003150 | |
| Drug | ifenprodil | 2.32e-06 | 71 | 276 | 8 | CID000003689 | |
| Drug | 6,7-dinitroquinoxaline | 2.53e-06 | 33 | 276 | 6 | CID002724608 | |
| Drug | 1m5b | 2.54e-06 | 9 | 276 | 4 | CID000447081 | |
| Drug | AC1L9FMM | 2.87e-06 | 73 | 276 | 8 | CID000444055 | |
| Drug | D-CPPene | 3.04e-06 | 34 | 276 | 6 | CID006435801 | |
| Drug | levo-dromoran tartrate | 3.05e-06 | 98 | 276 | 9 | CID000003918 | |
| Drug | kainite | 3.63e-06 | 35 | 276 | 6 | CID000164810 | |
| Drug | 13-methoxyibogamine | 3.88e-06 | 54 | 276 | 7 | CID000065749 | |
| Drug | 2-amino-3-phosphonopropionic acid | 3.89e-06 | 76 | 276 | 8 | CID000003857 | |
| Drug | enzacamene | RELN LIN7A CACNA1H CACNA1G CACNA1A CACNA1E GRIA4 GRIK4 GRIK5 SLC1A6 | 4.03e-06 | 129 | 276 | 10 | ctd:C038939 |
| Drug | C6H12NO5P | 4.31e-06 | 36 | 276 | 6 | CID000104962 | |
| Drug | glutamic acid diethyl ester | 4.31e-06 | 36 | 276 | 6 | CID000073960 | |
| Drug | CX546 | 4.38e-06 | 21 | 276 | 5 | CID000002890 | |
| Drug | cyclothiazide | 4.61e-06 | 103 | 276 | 9 | CID000002910 | |
| Drug | gamma-Glu-Gly | 5.10e-06 | 37 | 276 | 6 | CID000100099 | |
| Drug | Benzylpenicillin sodium [69-57-8]; Up 200; 11.2uM; MCF7; HT_HG-U133A | MON2 MCAM PTPN22 SCN1A SCN5A ADGRF1 WSCD1 PEX5L TASL MYOF LRRN3 IQCA1 | 5.51e-06 | 197 | 276 | 12 | 3577_UP |
| Drug | 17-isoprogesterone | MON2 UBR1 NCOA6 CYP3A7 CYP3A5 PPRC1 CYP46A1 ADCY2 GPR83 FAT2 SCGB1A1 OSBPL5 GFPT2 ALDH3A1 GNAS PZP ALPL RHCG GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 TDO2 NR3C1 GRM5 BBS10 LHCGR SLC22A9 MYOF BBS7 PAPPA | 5.96e-06 | 1170 | 276 | 33 | CID000004920 |
| Drug | 4CPG | 5.99e-06 | 38 | 276 | 6 | CID000005115 | |
| Drug | racemethorphan | 6.31e-06 | 107 | 276 | 9 | CID000003008 | |
| Drug | GYKI 52466 | 6.32e-06 | 58 | 276 | 7 | CID000003538 | |
| Drug | aminothiazole 6 | 6.99e-06 | 4 | 276 | 3 | CID005329388 | |
| Drug | N-(deoxyguanosin-8-yl)-IQ | 6.99e-06 | 4 | 276 | 3 | CID000130795 | |
| Drug | 3-pyridazinol 1-oxide | 6.99e-06 | 4 | 276 | 3 | CID000574311 | |
| Drug | acromelic acid B | 6.99e-06 | 4 | 276 | 3 | CID000158974 | |
| Drug | Brn 1074551 | 6.99e-06 | 4 | 276 | 3 | CID000120220 | |
| Drug | diCl-HQC | 6.99e-06 | 4 | 276 | 3 | CID003018579 | |
| Drug | YM90K | 7.10e-06 | 23 | 276 | 5 | CID005486547 | |
| Drug | gabapentin | SCN5A CACNA1H CACNA1G GFPT2 CACNA1A CACNA1E GRIA1 GRIA4 GRIK4 GRIK5 GRM5 | 7.25e-06 | 169 | 276 | 11 | CID000003446 |
| Drug | octylmethoxycinnamate | RELN LIN7A CACNA1H CACNA1G CACNA1A CACNA1E GRIA4 GRIK4 GRIK5 SLC1A6 | 7.86e-06 | 139 | 276 | 10 | ctd:C118580 |
| Drug | melatonin | CYP3A7 CYP3A5 PPRC1 ADCY2 ALPL CACNA1A GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 TDO2 NR3C1 GRM5 OPRK1 LHCGR ASMTL | 8.75e-06 | 443 | 276 | 18 | CID000000896 |
| Drug | Biliton | 9.46e-06 | 41 | 276 | 6 | CID000002974 | |
| Drug | 1NaPP1 | 9.69e-06 | 12 | 276 | 4 | CID000004877 | |
| Drug | themisone | 9.69e-06 | 12 | 276 | 4 | CID000016235 | |
| Drug | AC1L2VU3 | 9.69e-06 | 12 | 276 | 4 | CID000129572 | |
| Drug | gavestinel | 1.10e-05 | 25 | 276 | 5 | CID006450546 | |
| Drug | LY 300164 | 1.26e-05 | 43 | 276 | 6 | CID000126756 | |
| Drug | aurintricarboxylic acid | 1.50e-05 | 91 | 276 | 8 | CID000002259 | |
| Drug | L-689,560 | 1.64e-05 | 27 | 276 | 5 | CID000121918 | |
| Drug | philanthotoxin | 1.65e-05 | 45 | 276 | 6 | CID000115201 | |
| Drug | AC1L1YEG | 1.73e-05 | 5 | 276 | 3 | CID000063114 | |
| Drug | Chicago acid | 1.73e-05 | 5 | 276 | 3 | CID000065740 | |
| Drug | ipenoxazone | 1.73e-05 | 5 | 276 | 3 | CID000065882 | |
| Drug | pBB-PzDA | 1.73e-05 | 5 | 276 | 3 | CID000124528 | |
| Drug | CHEBI:570577 | 1.73e-05 | 5 | 276 | 3 | CID011334126 | |
| Drug | 1-BCP | 1.73e-05 | 5 | 276 | 3 | CID000001370 | |
| Drug | irampanel | 1.73e-05 | 5 | 276 | 3 | CID003038472 | |
| Drug | LY395153 | 1.73e-05 | 5 | 276 | 3 | CID000656707 | |
| Drug | bromowillardiine | 1.73e-05 | 5 | 276 | 3 | CID000167842 | |
| Drug | 3-hydroxy-2-quinoxalinecarboxylic acid | 1.73e-05 | 5 | 276 | 3 | CID000071001 | |
| Drug | beta-N-oxalylaminoalanine | 1.73e-05 | 5 | 276 | 3 | CID000107978 | |
| Drug | 5-h PCA | 1.73e-05 | 5 | 276 | 3 | CID000129091 | |
| Drug | kynurenic acid | 1.83e-05 | 122 | 276 | 9 | CID000003845 | |
| Drug | L-Glutamic Acid | 1.84e-05 | 68 | 276 | 7 | DB00142 | |
| Drug | DCG-IV | 1.84e-05 | 68 | 276 | 7 | CID000115114 | |
| Drug | oriens | 1.93e-05 | 154 | 276 | 10 | CID000161645 | |
| Drug | C-PP | 1.97e-05 | 28 | 276 | 5 | CID000001228 | |
| Disease | Intellectual Disability | RALGAPA1 GAMT LAMA1 SCN1A SLC5A6 SCN8A CACNA1G TAF1 GNAS TSEN15 PHIP DYNC1H1 CACNA1E GRIA1 MTF1 BBS7 MACF1 | 7.26e-07 | 447 | 265 | 17 | C3714756 |
| Disease | Profound Mental Retardation | 4.92e-06 | 139 | 265 | 9 | C0020796 | |
| Disease | Mental deficiency | 4.92e-06 | 139 | 265 | 9 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 4.92e-06 | 139 | 265 | 9 | C0025363 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 6.95e-06 | 145 | 265 | 9 | DOID:1289 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | RELN PDE9A MAP2 ABCA13 ADCY2 SCN8A CACNA1A GRIA1 GRIA3 GRIK4 GRIK5 TDO2 NR3C1 GRM5 SLC1A6 SEC24C | 7.63e-06 | 477 | 265 | 16 | C0005586 |
| Disease | Schizophrenia | RELN CYP3A5 ABCA13 LAMA1 CSMD2 ALDH3A1 GNAS TAPBP MED12 GRIA1 GRIA3 GRIA4 GRIK3 GRIK4 GRIK5 TDO2 NR3C1 GRM5 SLC1A6 VPS35 ATM | 5.47e-05 | 883 | 265 | 21 | C0036341 |
| Disease | Colorectal Carcinoma | PCSK2 ACAP1 MAP2 ABCA13 LAMA1 ZBTB8B ABCC8 VPS13A UQCRC2 GNAS PZP PHIP DNAH3 RBP3 GRIK3 PTPRU PEX5L SLC22A9 | 7.37e-05 | 702 | 265 | 18 | C0009402 |
| Disease | Major Depressive Disorder | 7.58e-05 | 243 | 265 | 10 | C1269683 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 8.20e-05 | 10 | 265 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 8.20e-05 | 10 | 265 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 1.19e-04 | 163 | 265 | 8 | DOID:1826 (implicated_via_orthology) | |
| Disease | Unipolar Depression | 1.28e-04 | 259 | 265 | 10 | C0041696 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.48e-04 | 12 | 265 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Familial hemiplegic migraine | 2.40e-04 | 3 | 265 | 2 | cv:C0338484 | |
| Disease | Respiration Disorders | 2.40e-04 | 3 | 265 | 2 | C0035204 | |
| Disease | Familial or sporadic hemiplegic migraine | 2.40e-04 | 3 | 265 | 2 | cv:CN295307 | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 2.40e-04 | 3 | 265 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | central nervous system disease (implicated_via_orthology) | 3.68e-04 | 16 | 265 | 3 | DOID:331 (implicated_via_orthology) | |
| Disease | Drug-induced agranulocytosis | 3.68e-04 | 16 | 265 | 3 | HP_0012235 | |
| Disease | Familial intrahepatic cholestasis of pregnancy | 4.76e-04 | 4 | 265 | 2 | C3489728 | |
| Disease | exfoliation syndrome | 4.76e-04 | 4 | 265 | 2 | EFO_0004235 | |
| Disease | tacrolimus measurement | 4.76e-04 | 4 | 265 | 2 | EFO_0008458 | |
| Disease | migraine (implicated_via_orthology) | 4.76e-04 | 4 | 265 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 4.76e-04 | 4 | 265 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | Kartagener syndrome (is_implicated_in) | 4.76e-04 | 4 | 265 | 2 | DOID:0050144 (is_implicated_in) | |
| Disease | Ciliopathies | 4.87e-04 | 110 | 265 | 6 | C4277690 | |
| Disease | Mental Depression | 5.17e-04 | 254 | 265 | 9 | C0011570 | |
| Disease | Dystonia | 1.08e-03 | 86 | 265 | 5 | C0013421 | |
| Disease | Psychosexual Disorders | 1.18e-03 | 6 | 265 | 2 | C0033953 | |
| Disease | Frigidity | 1.18e-03 | 6 | 265 | 2 | C0016722 | |
| Disease | Orgasmic Disorder | 1.18e-03 | 6 | 265 | 2 | C0029261 | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 1.18e-03 | 6 | 265 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | Hypoactive Sexual Desire Disorder | 1.18e-03 | 6 | 265 | 2 | C0020594 | |
| Disease | Sexual Arousal Disorder | 1.18e-03 | 6 | 265 | 2 | C0036902 | |
| Disease | Epilepsy, Generalized | 1.18e-03 | 6 | 265 | 2 | C0014548 | |
| Disease | depressive symptom measurement, response to antidepressant | 1.20e-03 | 88 | 265 | 5 | EFO_0007006, GO_0036276 | |
| Disease | Depressive disorder | 1.28e-03 | 289 | 265 | 9 | C0011581 | |
| Disease | late-onset Alzheimers disease | 1.38e-03 | 292 | 265 | 9 | EFO_1001870 | |
| Disease | Epilepsy, Absence, Atypical | 1.64e-03 | 7 | 265 | 2 | C0751124 | |
| Disease | Juvenile Absence Epilepsy | 1.64e-03 | 7 | 265 | 2 | C4317339 | |
| Disease | Childhood Absence Epilepsy | 1.64e-03 | 7 | 265 | 2 | C4281785 | |
| Disease | Akinetic Petit Mal | 1.64e-03 | 7 | 265 | 2 | C0001890 | |
| Disease | Absence Seizure Disorder | 1.64e-03 | 7 | 265 | 2 | C4553705 | |
| Disease | Epilepsy, Minor | 1.64e-03 | 7 | 265 | 2 | C4552765 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 1.64e-03 | 7 | 265 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | Absence Epilepsy | 1.64e-03 | 7 | 265 | 2 | C0014553 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.64e-03 | 7 | 265 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | status epilepticus (biomarker_via_orthology) | 2.12e-03 | 100 | 265 | 5 | DOID:1824 (biomarker_via_orthology) | |
| Disease | chemotherapy-induced alopecia, methylcobalamin deficiency type cblE | 2.17e-03 | 8 | 265 | 2 | EFO_0005400, MONDO_0009354 | |
| Disease | Cholestasis of pregnancy | 2.17e-03 | 8 | 265 | 2 | C0268318 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 2.17e-03 | 8 | 265 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | Testotoxicosis | 2.17e-03 | 8 | 265 | 2 | C1504412 | |
| Disease | MITOCHONDRIAL COMPLEX III DEFICIENCY (disorder) | 2.17e-03 | 8 | 265 | 2 | C1852372 | |
| Disease | Psychotic Disorders | 2.21e-03 | 101 | 265 | 5 | C0033975 | |
| Disease | body weight | RALGAPA1 PDE1C RELN EYA2 DNAH14 TTC19 ABCC8 GNAS TBC1D21 TSEN15 NIPBL DOCK1 OCA2 GRIK5 E4F1 ZSWIM6 MLLT10 TXNDC11 LHCGR SYT16 IPO9 PAPPA | 2.42e-03 | 1261 | 265 | 22 | EFO_0004338 |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 2.67e-03 | 31 | 265 | 3 | DOID:3328 (biomarker_via_orthology) | |
| Disease | Gastrointestinal Hemorrhage | 2.77e-03 | 9 | 265 | 2 | C0017181 | |
| Disease | non-melanoma skin carcinoma | 2.86e-03 | 265 | 265 | 8 | EFO_0009260 | |
| Disease | unipolar depression, bipolar disorder | 2.94e-03 | 156 | 265 | 6 | EFO_0003761, MONDO_0004985 | |
| Disease | cancer (implicated_via_orthology) | 3.06e-03 | 268 | 265 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | Disorder of eye | 3.17e-03 | 212 | 265 | 7 | C0015397 | |
| Disease | 3-methyl-2-oxobutyrate measurement | 3.45e-03 | 10 | 265 | 2 | EFO_0021020 | |
| Disease | hair colour measurement, eye colour measurement, skin pigmentation measurement | 3.45e-03 | 10 | 265 | 2 | EFO_0007009, EFO_0007822, EFO_0009764 | |
| Disease | Seizures | 3.69e-03 | 218 | 265 | 7 | C0036572 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 3.86e-03 | 71 | 265 | 4 | EFO_0007878, EFO_0007979 | |
| Disease | Prescription Drug Abuse | 3.87e-03 | 115 | 265 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 3.87e-03 | 115 | 265 | 5 | C0236969 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.87e-03 | 115 | 265 | 5 | C0029231 | |
| Disease | Drug habituation | 3.87e-03 | 115 | 265 | 5 | C0013170 | |
| Disease | Drug abuse | 3.87e-03 | 115 | 265 | 5 | C0013146 | |
| Disease | Drug Use Disorders | 3.87e-03 | 115 | 265 | 5 | C0013222 | |
| Disease | Drug Dependence | 3.87e-03 | 115 | 265 | 5 | C1510472 | |
| Disease | Substance Dependence | 3.87e-03 | 115 | 265 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 3.87e-03 | 115 | 265 | 5 | C0038586 | |
| Disease | obsolete aging | 3.90e-03 | 279 | 265 | 8 | GO_0007568 | |
| Disease | Substance abuse problem | 4.02e-03 | 116 | 265 | 5 | C0740858 | |
| Disease | Primary ciliary dyskinesia | 4.11e-03 | 36 | 265 | 3 | cv:C0008780 | |
| Disease | insulin sensitivity measurement, response to polyunsaturated fatty acid supplementation | 4.19e-03 | 11 | 265 | 2 | EFO_0004471, EFO_0009131 | |
| Disease | body fat percentage | RALGAPA1 PDE1C RELN CAMTA1 MLLT10 SYT16 IPO9 RALGPS1 MACF1 IGSF9B SENP7 | 4.91e-03 | 488 | 265 | 11 | EFO_0007800 |
| Disease | temporal pole volume measurement | 5.00e-03 | 12 | 265 | 2 | EFO_0010334 | |
| Disease | chronic kidney disease | 5.54e-03 | 235 | 265 | 7 | EFO_0003884 | |
| Disease | Depression, Bipolar | 5.64e-03 | 79 | 265 | 4 | C0005587 | |
| Disease | mood disorder | 5.87e-03 | 13 | 265 | 2 | EFO_0004247 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 5.92e-03 | 364 | 265 | 9 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | response to simvastatin, myopathy | 5.94e-03 | 41 | 265 | 3 | EFO_0004145, GO_1903491 | |
| Disease | RS-warfarin measurement | 6.08e-03 | 128 | 265 | 5 | EFO_0803325 | |
| Disease | tetralogy of Fallot (implicated_via_orthology) | 6.81e-03 | 14 | 265 | 2 | DOID:6419 (implicated_via_orthology) | |
| Disease | Bardet-Biedl syndrome (is_implicated_in) | 6.81e-03 | 14 | 265 | 2 | DOID:1935 (is_implicated_in) | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 6.81e-03 | 14 | 265 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | X-12063 measurement | 6.87e-03 | 186 | 265 | 6 | EFO_0021283 | |
| Disease | bilirubin measurement | UBR1 PIEZO1 TTC19 OSBPL5 ADGRL2 PHIP FAT4 OR10Z1 MTF1 DNAH11 | 6.99e-03 | 442 | 265 | 10 | EFO_0004570 |
| Disease | Alzheimer disease, polygenic risk score | ABCA7 DNAH14 FSIP2 DST ALPL CUL2 CACNA1E GRIA1 NIBAN2 ZSWIM6 RESF1 LY75 | 7.09e-03 | 586 | 265 | 12 | EFO_0030082, MONDO_0004975 |
| Disease | Autism Spectrum Disorders | 7.29e-03 | 85 | 265 | 4 | C1510586 | |
| Disease | severe acute respiratory syndrome, COVID-19 | RELN MYO7A LYST LIN7A TMEM132C CAMTA1 TBL1X COL6A3 P2RY8 WDFY4 | 7.54e-03 | 447 | 265 | 10 | EFO_0000694, MONDO_0100096 |
| Disease | Osteopenia | 7.81e-03 | 15 | 265 | 2 | C0029453 | |
| Disease | lifestyle measurement, anxiety disorder measurement | 8.05e-03 | 137 | 265 | 5 | EFO_0007795, EFO_0010724 | |
| Disease | Endogenous depression | 8.18e-03 | 46 | 265 | 3 | C0011573 | |
| Disease | Primary Ciliary Dyskinesia | 8.68e-03 | 47 | 265 | 3 | C4551720 | |
| Disease | Ataxia, Motor | 8.87e-03 | 16 | 265 | 2 | C0278161 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MAVDLLSAQEPVTFR | 1 | Q86Y25 | |
| VSLAVSIPDMVFVQT | 171 | O00590 | |
| IEENSNVILPIMFSS | 376 | Q16537 | |
| DTFPAAIMTVFQILT | 651 | O00555 | |
| VSNVVSLVDIYPTML | 351 | Q6UWY0 | |
| SLQVPELTMEEFLQE | 2351 | Q9HCE0 | |
| EPVLRFDQMLSESVT | 276 | Q8IWZ6 | |
| MIQLTATPVSALVDE | 1 | Q14032 | |
| PESLFELNSVMTVRA | 371 | P59826 | |
| PTSLMDVFPTVVQLV | 411 | P51689 | |
| ETIMLQTLGFEITIE | 136 | O60583 | |
| ESLSMLPTNVSEELV | 451 | Q9Y6Y1 | |
| VLSPEEFMVLLDSVL | 296 | Q8TDL5 | |
| IQPTDIMASEAEFTV | 3466 | Q7Z408 | |
| MSLAVDILPSAIEVQ | 1931 | Q6UVK1 | |
| DTFPAAIMTVFQILT | 641 | Q15878 | |
| FQRSLPETIISMASL | 471 | Q5T601 | |
| ISSQLMFTISQVTPL | 91 | O95971 | |
| LDMVVNETLRLFPVA | 356 | P20815 | |
| ELSENMASLLATIIP | 141 | P30838 | |
| TILVTDLNDNVPMFI | 1516 | Q6V0I7 | |
| ILEIRETSFQMLPIS | 586 | Q9NZU0 | |
| SPYVTELIMESNVEL | 51 | Q9C0F1 | |
| MPTVFLLTDAQVLDE | 2906 | Q96DT5 | |
| MIETLFIPVTNESST | 2141 | Q86UQ4 | |
| IVETADMLQAPLFTA | 241 | Q9P2G1 | |
| VSMPTENIVLEVAVL | 661 | O95490 | |
| PLTIAMETANADIVT | 676 | Q15027 | |
| TLEAFAVIVTQMLAL | 311 | Q8TC27 | |
| TIPTIGFNVEMIELE | 41 | Q8N4G2 | |
| VIDTFQASFLLPEVM | 286 | Q9UBZ4 | |
| TSEISPELFMQLVPQ | 681 | Q7L7V1 | |
| RMVIVTETIQPLFST | 256 | Q8TAM1 | |
| LSSAVTDLNIIMEPT | 131 | Q6IPU0 | |
| PLTAVEFITAITSMN | 766 | Q86XH1 | |
| LNTMVPISLYVSVEV | 396 | O43520 | |
| NEVIPADMVLLFSTD | 186 | Q9P241 | |
| MSFVPASFTLVLIEE | 1546 | Q8IZY2 | |
| VLALAAMLVVPQAET | 11 | Q9HC84 | |
| VPLMVSLEISLEAAE | 411 | O95072 | |
| QTLSFSFMVLQDIPV | 1431 | P20742 | |
| DNVTTMLLFTPVTIR | 441 | Q04671 | |
| LTVTDRPVMDVAFVQ | 486 | P69849 | |
| DILMEFLLNVTTAPE | 131 | P22695 | |
| PEEFASQITLMDIPV | 51 | Q5JS13 | |
| AETLLLSVFQDMVIV | 586 | Q4ADV7 | |
| IIPENFSVFSLIREM | 251 | Q9Y2R2 | |
| ILEALMVPTSQGFTE | 346 | Q96TA1 | |
| SPSVIFMINLSVTDL | 56 | Q86VZ1 | |
| SVTDLMLASVLPFQI | 66 | Q86VZ1 | |
| MPLVVAVLENLDSVF | 51 | O60271 | |
| SLPLLELQEIMTSVA | 1036 | O00763 | |
| VAPIIDLMAVSNALF | 386 | Q86YJ7 | |
| EAPRTLLEFETQSMV | 426 | Q96GW7 | |
| MVARILPFLSTEQAA | 596 | Q86TB9 | |
| LPFLSTEQAADILMT | 601 | Q86TB9 | |
| VIFVSDIDMLLSSQV | 581 | Q5HY92 | |
| LTVTDRPVMDVAFVQ | 486 | Q5JPE7 | |
| ALADLVPVDVVVNMS | 271 | Q8WVX9 | |
| KEIQLPTTMTTFAEI | 1101 | P41594 | |
| PMDVETTLSQVYILT | 516 | P22888 | |
| TADMATLTVVQPLTL | 11 | O14910 | |
| DLQVTLIPTFDSVAM | 1006 | Q66K74 | |
| ISEINLSPMEISTFR | 1126 | Q16706 | |
| ILLEQQMIFTPEESE | 281 | Q4G1C9 | |
| QLFSILEELAMVTSL | 336 | Q7LDG7 | |
| VEQSSVFLMPSRVEI | 276 | Q9UKP3 | |
| TISAMSEPIEVVDLL | 891 | Q02846 | |
| MAITLQPSDLIFEFA | 1 | Q99607 | |
| SVQEQLPYSVTLISM | 141 | P53671 | |
| TIPVLDALAQSMITE | 1641 | Q03001 | |
| MQVTVFDLPDIIELA | 476 | O95671 | |
| IFQVMISRSTTPDLI | 4556 | Q2LD37 | |
| MADVTFPSVPQIVSL | 2366 | Q5SZK8 | |
| VSFVLEMINTLPFII | 191 | Q5JUK3 | |
| LAVETFSELPQVRAM | 251 | Q9Y2U2 | |
| LDLSMNDFTTIPLAV | 181 | Q96DD0 | |
| PTFVVQVSTEQLLMS | 851 | Q96Q04 | |
| ESLPETLVIFVADMS | 126 | O43237 | |
| LISVRLVVNFDMPSS | 511 | Q5T1V6 | |
| FSEIVKMPIENLSSI | 3016 | Q5CZC0 | |
| VSRSPIMIDQIASFI | 4236 | Q5CZC0 | |
| ITEMVKQLIFSSIPE | 5791 | Q5CZC0 | |
| EILLQLSASVPVDVM | 281 | P49005 | |
| NLAAFLTVERMVSPI | 651 | P42263 | |
| NLAAFLTVERMVSPI | 641 | P48058 | |
| PLALMFEDVTVAATN | 601 | Q9ULL4 | |
| NIVEEEPLMLFTTDF | 2206 | Q9NYQ8 | |
| MTEFIFLVLSPNQEV | 1 | Q8NGF9 | |
| IDFIVEPTFTVLTDM | 431 | Q14123 | |
| DLPVTILFMEAAILQ | 341 | Q8IYB4 | |
| ISLLTTDDAMVSIDP | 51 | O76083 | |
| LFLVTNEVMPLQDSI | 511 | Q8TAT6 | |
| SLTADDVMSLTQVIP | 321 | Q6UY01 | |
| ILQVSSMGITPFFVE | 1411 | Q6KC79 | |
| QDFITSLLPDMEATL | 996 | O60449 | |
| NELFTTVLDMLSVLI | 1576 | Q93074 | |
| SIEFPEMLAEIITNQ | 746 | P04150 | |
| TTAVMTDLPVISNIL | 736 | Q7Z3U7 | |
| SESIILPMNVTVRDI | 1511 | Q13219 | |
| MAQDIPLTPIFTDTV | 276 | Q9Y2J8 | |
| VLDAQIEMLSPFEAV | 211 | Q9BT25 | |
| TSLFIVNLAVADIMI | 106 | Q9NYM4 | |
| NLLTPDMITEFETLQ | 526 | Q86Y91 | |
| RVILSNMVSISSEPF | 296 | Q53HC9 | |
| VFVAVSLPTLASNVM | 1001 | Q9Y2A7 | |
| IVQESPFLTMDLLES | 1091 | Q9Y2A7 | |
| TSLENLIMEITAPDS | 4391 | Q9UPN3 | |
| IDEIIMTSVLFNSIS | 856 | P78509 | |
| SPLVEETLQMLTTSV | 481 | A2A3N6 | |
| DQLIAMTYTVVTPLL | 271 | Q8NGY1 | |
| IILVTIADSALQSPM | 46 | Q9H209 | |
| AESLTFTPLEDMIFL | 491 | Q92729 | |
| IPENTPETVVMVFSI | 356 | Q9Y5F2 | |
| PETVVMVFSIQDIDS | 361 | Q9Y5F2 | |
| VTIPVLFNESTMAQL | 616 | A8MVW0 | |
| ITPVFINSSSIIQVM | 1656 | Q14686 | |
| DPSLSEMVVVAIQIL | 306 | P05186 | |
| QAPLETVVMTECLLS | 291 | O95522 | |
| MFEVQDLAVASPATV | 1986 | Q9P2D7 | |
| FISNLPEIVVELLMT | 1336 | Q13315 | |
| LPFNMRDAIIASVLT | 151 | Q08462 | |
| ELMLTVQSLLFEPSL | 516 | Q9C0G6 | |
| IRFPLMQSSELVDSV | 251 | Q53HC5 | |
| SAVDMDILFPLDSVI | 11 | A6NFR6 | |
| SVFMVEISPLENAIE | 1481 | Q14185 | |
| ELTELPVMVELASDF | 391 | O94808 | |
| IPLAEMEALSLTSEI | 1976 | O43497 | |
| LAFTVMELSRQPEIV | 311 | Q9Y6A2 | |
| LIIPTMETARQSFFL | 2046 | Q8TD57 | |
| EELTQPVARTMDFLS | 466 | P15391 | |
| EDLFLTSPMEIVTQQ | 71 | Q6ZU35 | |
| ISAMSEPIEVVDLLN | 896 | P51841 | |
| NLMVSTEPLALTETD | 3096 | P12111 | |
| ALPIVAIENILSFMS | 66 | Q9NVF7 | |
| TFPESLLEEMIATLQ | 511 | Q53R41 | |
| SRIIVMSFPLDNVDI | 71 | O75061 | |
| TQENMPTLFVESVLE | 331 | Q13617 | |
| VAPSDTVLMFNVALV | 746 | Q6PD62 | |
| EAIETIVAAMSNLVP | 101 | P63092 | |
| TLQEMLSFEETVPVP | 246 | P48664 | |
| QDPQLSIFIDLVSIM | 616 | Q0VDD8 | |
| IQEFMTKLSDILTIP | 886 | Q8IY85 | |
| EMADVLNPLITAVFL | 446 | Q9NRY5 | |
| DILSEPAALSVISNM | 236 | Q99698 | |
| DVVNLFPATFLTTEM | 321 | Q6MZM0 | |
| LTDNVMITVDIIPSG | 496 | Q9H992 | |
| TLEPMEIRTFLASVQ | 991 | O00754 | |
| TIMFEETQVPALLEA | 186 | Q14353 | |
| TEFTREVTDTQMPLV | 171 | Q96P70 | |
| IIMRENFIPTIVNFS | 3341 | Q14204 | |
| FIIQTIPRDVNTAVM | 61 | Q14558 | |
| ITIATPESLTEQVAM | 711 | Q66K89 | |
| QSMDLVELVSLFPTL | 396 | P22304 | |
| LDMVVNETLRLFPVA | 356 | P24462 | |
| ILEFIEDLMNPSVVS | 546 | Q8IXB1 | |
| EIRSLVEPLSMIQFD | 581 | A6NE01 | |
| LPQIDIVNISDSFEM | 56 | P42261 | |
| NLAAFLTVERMESPI | 656 | Q13003 | |
| TTLVVTTILENPYLM | 416 | Q16099 | |
| AAFLTVQRMDVPIES | 641 | Q16099 | |
| AFLTVQRMEVPVESA | 641 | Q16478 | |
| TPTAILTQDSLQMFL | 686 | Q9NZM4 | |
| ITLEEIEMSAALPIN | 1696 | O95180 | |
| AVITSLLDQIPEMFA | 596 | P53992 | |
| ALQLLMPTLESETEA | 386 | Q5VV67 | |
| LQRFMAVSDVPSLSV | 561 | Q5VW36 | |
| LNLSEMLIDAPTISE | 3561 | Q8TE73 | |
| EFILMSFSSLPTEIQ | 11 | Q9H207 | |
| LSVVDLSFSAVIMPE | 66 | Q8NH74 | |
| ELFIITQLQSMPSRE | 511 | O94955 | |
| DPDLLVDLFTSSVQM | 386 | Q03933 | |
| QLLSALTDPSVVIMA | 116 | Q9H0X9 | |
| MNSAFSPIVILTERV | 616 | Q96PC5 | |
| TVIVPKMLVNFLSET | 76 | Q8NGR5 | |
| TTVIVPKMLVNFLSE | 111 | Q8NGR2 | |
| SSIFVNEIVQMTEAP | 191 | Q8NGR8 | |
| LALADALVTTTMPFQ | 101 | P41145 | |
| DTMISLLSEPQELLV | 326 | P43121 | |
| PFRVQAASEMLLTAV | 751 | Q6ZUA9 | |
| MVELVISPSLTVNSD | 1 | O00167 | |
| TFQIILSEPLMAVLE | 1856 | P0C091 | |
| DTTVTMLANLVPFTV | 176 | P59539 | |
| TQPTLSDIVVTLVEM | 86 | Q7Z7C8 | |
| SMLISGQSIPDELVI | 81 | Q5TCS8 | |
| LELPLITCESVQMSS | 481 | Q9BQF6 | |
| LENKSLEMTFIPTIE | 461 | P19320 | |
| VSSTPLVDFLMQLED | 111 | Q12962 | |
| IIPSALDFVSQDEML | 31 | Q8TF05 | |
| DLQVTDILPQMITLS | 531 | Q53GS9 | |
| NLDMLSTLITFLDPV | 206 | Q8IYX1 | |
| VALFQLSDVTLMISV | 581 | Q17RD7 | |
| IVPLAMDTEVLNTAI | 421 | Q14DG7 | |
| VPLAMDTEILNTAVL | 431 | Q8N3T6 | |
| EVGMTTIQVLSPLSD | 636 | Q8N3T6 | |
| ILPLAMDTEIINTAI | 441 | Q6IEE7 | |
| VPFQLLTSLMDIDSL | 306 | P48775 | |
| LVAVVMDVFTDPDLL | 156 | Q2M2I3 | |
| NFPESESVLVLTVLM | 1286 | A0AVI2 | |
| ESVLVLTVLMPTEEA | 1291 | A0AVI2 | |
| INNMPELISIDSLAV | 291 | Q9H3W5 | |
| TETIIIMLEFIANLP | 81 | P04808 | |
| ITILSSEQMKEIFPE | 1106 | Q9HCM1 | |
| FVPQEMQTLREVLAT | 426 | Q8IVM8 | |
| FNSLATVTMEDLIRP | 371 | Q9Y289 | |
| PMVTLSSILESIIND | 1381 | P21675 | |
| DLSTISPAIIFESMF | 361 | Q14872 | |
| SLPATVTQIIMLFNT | 2321 | P25391 | |
| LTLIELPSVNTMEEE | 1566 | Q96Q15 | |
| DPFTDLTITMCIVLN | 716 | Q14524 | |
| QNISAIEPLIVFMFS | 296 | Q6AI14 | |
| AVAISQTLINPMEVL | 196 | Q8N5S1 | |
| TVFTIPESVFMELVL | 106 | Q9UJQ7 | |
| LVYEQIPATLITDSM | 216 | Q9BV20 | |
| LLQFLVDTAMPASVI | 406 | Q6P9B9 | |
| SLVMPVALFNLIDTF | 431 | P78539 | |
| DIPVTIMDVFDQSAL | 216 | Q9NZD8 | |
| PESETMLIFQVFEAI | 91 | O60287 | |
| SVPAFVLATDLMVDV | 161 | Q96EM0 | |
| EASMVITESPAALQL | 236 | P27105 | |
| VNLVVMDPFVDLAIT | 761 | P35498 | |
| SISIFMNTAIPIAAV | 541 | Q09428 | |
| FAVLMALTSQEEDPV | 341 | Q9BY15 | |
| EVQFANVSTMEPIVL | 111 | P55197 | |
| ISMTTFTEPEVVFLQ | 86 | O95081 | |
| VLISLFELNTPEFTM | 1046 | Q7Z460 | |
| ISLFELNTPEFTMLL | 846 | O75122 | |
| SLSLIDAVMPDVVQT | 131 | O60907 | |
| INTLLMDELTVPTVV | 296 | Q96JJ7 | |
| MDELTVPTVVVLNTS | 301 | Q96JJ7 | |
| NSMLTPELQEAEVFI | 131 | Q7RTY3 | |
| QALAMSTLEELPTEL | 21 | Q5VXH4 | |
| SFQRVIETLLMDTPS | 26 | P11684 | |
| PQTIVLMSDLATTLD | 276 | Q6DKK2 | |
| DIVQIITDALLEMFP | 601 | Q9P2K2 | |
| ITDALLEMFPEITVE | 606 | Q9P2K2 | |
| FSTMLQEEPDLVSAI | 166 | Q8NBP0 | |
| ETFPTLRSMIEVLNT | 836 | Q8NBP0 | |
| TLVDEPESMVNLAFV | 271 | O94966 | |
| MSAQSVEEDSILIIP | 1 | P17028 | |
| LKPMEFILSQEDITT | 1316 | Q96RL7 | |
| PLFMQEPEEIVITSS | 446 | Q6GYQ0 | |
| ITVPMSEALSIAQDI | 916 | P10745 | |
| ESVQPFLASILEELM | 341 | Q9BZQ8 | |
| MTLDIASAFVAPVDL | 1176 | Q8WWQ0 | |
| MQLEEQVLTISSEIP | 86 | Q6NUQ1 | |
| EEINVIFMPANTTSI | 316 | Q96MW7 | |
| VLAVMQDLISEPSNI | 686 | Q9UPX0 | |
| ISFDPDDIITNIEMI | 511 | Q14247 | |
| PTQILASELIMTSVD | 236 | Q9HAI6 | |
| DMPSEDVVSLQVSLI | 341 | Q96QK1 | |
| LFLSIMPLESAVNVV | 671 | O95759 | |
| QQEPVLITMATVVLT | 146 | O15533 | |
| AESPLMNIEVVEVLT | 101 | Q96GC6 | |
| QALAMSTLEELPTEL | 21 | Q5TYX0 | |
| VSTFFLQTPLTELMD | 1721 | Q6ZS81 | |
| SISITALSVQMFTVP | 411 | Q8IWV7 | |
| SSLDMVELQPLLTEI | 461 | Q12815 | |
| TLVTDLMVLADELSP | 921 | Q8TBZ2 | |
| VMILEFLTVAVETQP | 916 | Q5SRE5 | |
| LQMPLFSDVLLTTSE | 391 | Q7Z7A4 | |
| VNLIVMDPFVDLAIT | 746 | Q9UQD0 | |
| TPTNFLILSMAITDF | 76 | Q9P1P5 | |
| QEVTLAEDFMVISIP | 346 | Q9H777 | |
| PEAEEITMISIQLAA | 2036 | O00507 | |
| LLDDLMPANEIVITS | 1196 | Q6AHZ1 | |
| ITTVPLVSEIQLMAA | 31 | Q9NV29 | |
| TMQITEEPEYLILTL | 751 | Q8NB14 | |
| SFTLPLDVMKNEIVT | 321 | P11137 | |
| VSPIQLLIMTFFQVT | 146 | Q9UBD6 | |
| LPMDTFTVARIDVSQ | 736 | Q6PKC3 | |
| ELDSLVASIMDAPTI | 176 | Q5TEC3 | |
| VLSPFVLQEIVMETL | 1726 | A7E2V4 | |
| TLITEQFMADPRLSL | 411 | Q9HCJ5 | |
| ALETNIIPSFVLMDI | 141 | Q9UBQ0 | |
| IIPSFVLMDIQASTV | 146 | Q9UBQ0 | |
| SDDQVPEAFLVMLLI | 1996 | Q92508 | |
| VLSPADMAAVFINLE | 231 | P52735 | |
| FALGISMTFINIPVE | 271 | Q5T9L3 | |
| SLVPTLREMVAFLNV | 496 | Q658N2 | |
| ETPEIDMFLNVATFL | 461 | O96006 | |
| DSLMTDETIANVPIL | 116 | Q9Y6B6 | |
| ASILQSMLEIADPIV | 351 | Q96MT1 | |
| VVVPMQIELLNSSIT | 1311 | Q6BDS2 | |
| PMSFTLAIVESDSTI | 136 | Q8WW01 | |
| AELTPLESAINVLEM | 166 | Q15554 | |
| TSPMLDESVIIQLVE | 651 | P45974 | |
| TSRVAPSILIEFINM | 616 | Q9Y487 | |
| SMLRLFETFLETAPQ | 131 | Q9H6D3 | |
| DLMPINLSLVEASSE | 436 | Q8NAP8 | |
| FTIAMVVAPELFTTE | 1381 | P35573 | |
| QVLLELSFPEIMAVS | 1506 | Q13402 | |
| IFSPVVKLNSEMDIT | 1231 | Q9NZM1 | |
| LDQPFMTDIIEASSI | 241 | P16519 |